rfhg_82689.1

Basic information about the TSS

---

TSS ID: rfhg_82689.1 Species: human Chr: chr6		Start: 42615114 End: 42615114 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK304070:21 GeneID: 23304 HGNC/MGI_ID: HGNC:21289 UniProt_ID: B4E215 Nearer transcript ids and distances:

Gene_name: ubiquitin protein ligase E3 component n-recognin 2 Gene_symbol: UBR2 Gene_synonyms: KIAA0349 bA49A4.1 dJ392M17.3 Gene_source: HGNC:21289

TATA-Box annotation

---

Distance to TSS:	51085
Nearest PromoterID:	NM_001184801
Entrez ID:	23304
Nearest Unigene:	Hs.529925
Nearest Refseq:	NM_015255
Nearest Ensembl:	ENSG00000024048
Gene Name:	ubiquitin protein ligase E3 component n-recognin 2
Gene Alias:	C6orf133|bA49A4.1|dJ242G1.1|dJ392M17.3
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBR2 p2@UBR2 p3@UBR2 p4@UBR2 p5@UBR2 p6@UBR2 p8@UBR2 p9@UBR2 p10@UBR2
Sample		p1@UBR2	p2@UBR2	p3@UBR2	p4@UBR2	p5@UBR2	p6@UBR2	p8@UBR2	p9@UBR2	p10@UBR2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.27	4.09	1.56	1.36	1.36	0.00	1.17	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	23.06	2.63	1.01	1.01	1.01	0.81	1.01	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	25.08	4.05	1.35	1.54	1.35	0.19	0.58	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.22	2.91	0.83	0.83	1.66	0.21	0.00	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	20.92	2.70	0.90	0.90	2.02	0.00	0.90	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.61	3.68	0.19	0.78	0.78	0.78	0.58	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	31.16	4.14	1.96	0.65	0.87	0.00	0.44	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.04	2.42	0.48	0.73	0.73	0.24	0.00	0.00	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	29.71	4.27	0.85	1.28	1.50	0.64	1.07	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	47.53	2.90	2.32	2.32	3.48	0.58	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.44	9.30	1.62	1.62	2.43	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	52.04	3.66	1.63	2.03	3.25	0.41	0.41	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.15	0.97	0.32	0.81	0.00	0.16	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.98	1.20	0.30	0.60	0.00	0.15	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.44	1.32	0.44	0.66	0.00	0.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.55	0.50	0.00	0.25	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.90	0.22	0.22	1.31	0.00	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.48	0.84	0.00	0.00	0.00	0.00	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.00	1.07	0.00	0.00	0.53	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.93	0.45	0.30	0.60	0.15	0.30	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.90	0.53	0.13	0.40	0.13	0.13	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.84	0.86	0.35	0.17	0.17	0.00	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.44	0.78	0.13	0.39	0.13	0.13	0.65	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.71	0.49	0.24	0.00	0.24	0.24	0.00	0.00	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.48	1.81	0.52	0.26	0.00	0.26	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	5.70	1.58	0.63	0.00	0.00	0.32	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.89	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	8.72	0.47	0.71	0.71	0.00	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.91	0.65	0.48	0.48	0.00	0.32	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.50	0.72	0.90	0.54	0.18	0.00	0.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.47	0.84	1.05	0.42	0.21	0.21	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.57	0.78	0.00	0.59	0.00	0.00	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.50	1.06	0.21	0.63	0.00	0.42	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	10.89	0.99	0.16	0.16	0.00	0.16	0.16	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.29	0.93	0.56	0.37	0.00	0.19	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.96	1.15	0.77	0.38	0.00	0.00	0.19	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.95	1.02	0.20	0.20	0.00	0.20	0.20	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.65	0.81	0.20	0.20	0.00	0.20	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	10.80	2.16	0.00	0.00	0.00	0.00	0.00	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.56	1.68	1.20	0.72	0.48	0.00	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.94	0.47	0.94	0.00	0.00	0.00	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.91	1.02	0.59	0.73	0.15	0.00	0.15	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.12	2.11	0.21	0.42	0.21	0.42	0.42	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.06	1.75	0.70	0.35	0.35	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.63	1.61	0.40	1.00	0.00	0.00	0.00	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.56	0.93	0.93	0.93	0.70	0.47	0.00	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.28	0.72	0.48	0.24	0.00	0.00	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.84	1.19	0.89	0.89	0.60	0.00	0.30	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.29	2.87	0.00	0.24	0.00	0.24	0.00	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.90	2.63	1.01	1.21	0.00	0.40	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.27	1.23	0.20	0.61	0.00	0.82	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.56	0.67	0.44	0.67	0.00	0.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	27.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.07	1.42	0.35	0.00	0.00	0.35	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.61	1.33	0.66	0.33	0.33	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.97	0.84	1.68	1.68	0.84	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.02	0.00	0.00	1.38	0.92	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.34	1.62	0.00	0.32	0.32	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	6.74	1.61	0.00	0.64	0.00	0.00	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.63	1.26	1.26	1.26	0.31	0.00	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9.53	2.24	0.56	0.56	0.00	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5.57	0.80	0.80	0.80	0.00	0.00	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.87	2.72	0.00	0.34	0.00	0.34	0.00	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.65	0.65	0.32	0.65	0.00	0.32	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.81	0.35	0.35	0.71	0.35	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	1.46	0.00	1.46	0.00	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.95	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	3.28	1.41	1.41	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.93	3.31	0.66	0.66	0.00	0.00	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	9.59	1.55	1.24	0.93	0.00	0.00	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.95	1.83	0.61	0.61	0.00	0.00	0.00	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	12.51	1.43	1.58	1.43	0.48	0.32	0.48	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	9.47	0.16	0.96	0.16	0.64	0.48	0.32	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	14.38	2.04	1.27	1.40	0.38	0.38	0.13	0.00	0.64
Adipocyte - omental, donor2	11474-119C7	5.98	1.49	1.49	2.99	0.00	0.00	1.49	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	11.72	0.00	1.00	0.33	0.00	0.67	0.67	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	9.57	0.64	1.28	1.91	0.00	0.00	0.64	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.58	1.35	0.45	0.00	0.00	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	9.21	0.17	0.52	0.35	0.00	0.00	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	23.08	1.37	1.17	1.17	0.39	0.78	0.20	0.00	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	19.05	0.51	1.54	1.03	0.00	0.00	0.26	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	23.14	1.39	2.23	0.84	0.00	1.12	0.28	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	25.28	1.76	2.35	2.35	0.59	1.18	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	25.50	1.45	1.77	1.13	0.32	0.32	0.24	0.00	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	23.88	1.29	1.94	0.97	0.00	0.32	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	19.73	2.13	1.07	1.07	0.53	1.07	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	1.11	0.56	1.67	0.56	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	17.88	0.83	0.42	1.25	0.00	0.83	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	17.58	1.00	1.51	1.51	0.00	1.51	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	16.36	1.31	2.62	0.98	0.33	0.33	0.98	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	12.48	2.13	0.61	0.91	0.00	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	2.87	0.22	0.22	0.00	0.00	0.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.08	0.00	0.00	0.00	0.00	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	6.48	0.90	0.36	0.54	0.18	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.55	0.62	0.41	0.82	0.00	0.21	0.00	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	14.19	0.92	0.92	2.52	0.11	0.00	0.34	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	6.37	0.49	0.98	0.73	0.24	0.24	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.99	1.35	1.35	2.70	0.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.51	0.87	1.74	0.87	0.00	1.30	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	2.14	0.00	2.14	0.00	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.77	1.20	0.60	0.90	0.00	0.00	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	2.53	1.26	1.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	2.64	0.00	0.66	0.00	0.00	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.82	0.97	0.65	0.32	0.00	0.32	0.32	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	0.97	1.46	1.46	0.00	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	1.78	0.00	1.78	0.00	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.14	0.38	0.75	0.38	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	0.73	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.41	1.32	1.65	1.15	0.49	0.00	0.00	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	0.00	1.36	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.43	0.60	0.60	1.06	0.30	0.15	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	5.89	0.54	0.00	1.61	0.00	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.23	0.76	0.38	0.76	0.57	0.00	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.95	0.80	0.80	0.80	0.53	0.00	0.27	0.00	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	0.00	0.98	0.98	0.00	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.63	0.83	1.16	1.00	0.33	0.00	0.00	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	0.00	3.60	0.00	0.00	0.00	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.86	0.51	0.86	0.86	0.51	0.17	0.00	0.00	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	0.49	1.94	0.97	0.49	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	8.35	0.00	1.14	0.76	0.00	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	2.42	0.00	1.21	0.00	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	0.00	1.14	0.57	0.00	0.57	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	3.85	0.64	1.07	0.64	0.00	0.00	0.21	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.16	1.03	1.03	1.03	0.00	0.00	0.00	0.00	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.22	0.47	1.41	0.00	0.00	0.00	0.47	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.14	1.29	0.64	0.96	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.85	1.43	0.71	0.00	0.00	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	0.00	0.00	1.17	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.92	1.20	1.20	0.60	0.60	0.00	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	1.19	2.38	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.59	1.02	2.03	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.84	0.76	2.55	0.76	0.00	0.00	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.08	0.00	0.64	1.27	0.00	0.00	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.88	0.86	0.86	0.86	0.00	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.77	0.64	0.00	0.85	0.00	0.00	0.00	0.00	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	1.45	0.87	0.58	0.00	0.00	0.29	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	1.89	0.00	0.94	0.00	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.41	0.85	0.85	0.51	0.17	0.00	0.00	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.00	1.29	1.29	0.86	0.21	0.21	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	1.20	0.60	1.80	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	0.00	2.92	0.00	0.00	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	4.14	0.92	0.46	0.69	0.23	0.00	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	0.00	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.08	0.25	1.02	1.78	0.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.57	0.62	2.06	1.24	0.41	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.26	0.61	0.92	0.31	0.31	0.31	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	7.65	0.48	0.96	1.43	0.48	0.00	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.65	1.11	1.11	1.11	0.44	0.67	0.00	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	0.00	1.53	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	0.55	1.11	0.55	0.00	0.00	0.55	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.15	0.26	1.06	0.53	0.53	0.00	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.91	1.09	1.45	0.73	0.36	0.00	0.36	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	8.60	0.98	0.49	0.74	0.12	0.12	0.12	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	5.82	0.86	0.00	0.17	0.17	0.34	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.99	0.00	0.21	0.00	0.21	0.21	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	12.90	4.18	0.70	0.35	0.00	0.35	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	14.56	1.13	1.13	0.97	0.65	0.65	0.16	0.00	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	14.62	1.94	1.04	1.04	0.00	1.04	0.30	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	27.18	1.83	1.15	0.80	0.23	0.57	0.23	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	20.80	2.88	1.25	1.75	0.88	0.25	0.25	0.00	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	22.76	1.82	1.25	1.82	0.23	0.11	0.23	0.00	0.23
Basophils, donor1	12241-129G9	51.78	2.09	1.31	0.52	0.26	2.35	0.00	0.00	0.00
Basophils, donor2	12242-129H1	79.01	3.61	9.38	2.16	2.53	1.08	0.36	0.00	2.53
Basophils, donor3	12243-129H2	30.72	1.18	1.47	0.88	1.03	0.73	0.00	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	3.23	0.86	0.22	0.22	0.43	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	0.00	0.00	0.00	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	1.26	0.00	0.00	1.88	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	3.74	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.14	0.69	0.23	0.69	0.00	0.23	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	7.92	0.90	0.54	0.72	0.36	0.18	0.18	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	19.89	1.55	1.34	0.72	2.58	0.10	0.00	0.00	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	48.44	3.49	3.73	1.63	3.73	0.47	0.47	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.34	2.88	2.56	1.28	0.96	0.64	0.32	0.00	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	10.34	10.34	0.00	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	28.18	1.69	1.69	1.13	0.00	0.00	0.56	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	24.68	1.48	2.60	1.30	0.19	0.37	0.19	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	30.30	2.41	2.20	1.32	0.66	1.10	0.00	0.00	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	66.52	2.83	1.98	0.85	0.28	3.40	0.28	0.00	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	43.97	2.27	4.55	1.52	0.38	1.14	0.38	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	51.61	1.64	1.97	0.99	0.66	1.64	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	73.58	3.04	4.34	2.17	2.46	3.32	0.72	0.00	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	55.52	0.91	3.92	1.51	1.21	1.81	0.00	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	84.57	4.50	5.45	1.66	2.13	4.50	0.71	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.30	1.51	2.18	0.84	1.17	2.34	0.33	0.00	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	28.98	1.93	1.66	0.55	0.28	1.10	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	26.28	1.98	0.74	0.99	1.74	0.50	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	18.21	1.37	0.59	0.20	0.39	0.98	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	22.26	1.42	0.71	0.53	0.00	0.53	0.00	0.00	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	28.73	1.96	0.87	0.87	0.22	1.31	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	20.37	1.17	1.17	0.70	0.47	1.17	0.23	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	30.10	1.58	1.06	0.53	1.06	1.58	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	27.73	1.11	1.11	2.22	0.00	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	35.85	1.49	2.08	0.45	0.89	1.64	0.00	0.00	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	32.33	1.40	1.00	1.00	0.60	1.60	0.00	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	43.72	2.71	1.67	1.25	0.42	1.04	0.21	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	24.71	0.92	1.37	1.60	0.00	0.23	0.00	0.00	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.62	1.81	0.90	0.00	0.23	0.23	0.00	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	27.50	0.87	0.87	1.75	0.87	0.87	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	52.18	2.69	1.61	1.08	1.61	2.15	0.00	0.00	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	39.60	2.27	1.57	0.70	1.22	1.40	0.00	0.00	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	52.60	2.52	4.21	1.26	0.84	0.42	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.04	0.00	0.92	0.18	1.10	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	21.14	1.06	0.35	0.35	0.00	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	27.20	1.75	0.44	0.88	0.00	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.55	2.09	1.92	0.70	0.52	1.57	0.35	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	25.65	0.74	1.86	0.00	0.00	0.00	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	40.74	3.23	0.86	1.51	0.86	0.00	0.43	0.00	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.43	0.82	1.23	0.00	0.41	1.64	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	21.33	1.16	0.70	0.46	0.23	1.16	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	22.97	1.62	0.93	0.23	0.46	1.16	0.23	0.00	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	45.77	2.18	1.96	0.22	0.22	1.53	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	46.66	1.85	2.54	1.15	0.23	3.00	0.00	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	41.37	1.52	2.17	1.30	0.22	1.95	0.22	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	74.12	2.34	3.43	2.02	0.16	2.96	0.31	0.00	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	71.25	3.32	3.49	2.97	0.70	2.62	0.70	0.00	1.22
CD14+CD16- Monocytes, donor3	11910-125G2	100.11	2.23	5.13	2.45	0.89	3.12	0.00	0.00	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	63.03	2.55	2.30	1.53	1.02	2.30	0.51	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	60.38	1.98	1.76	1.54	1.76	1.76	0.00	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	69.69	3.58	1.05	1.89	0.84	1.68	0.21	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	6.10	6.10	0.00	4.06	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	54.24	6.10	8.81	4.75	2.71	1.36	0.00	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	62.14	7.25	9.32	4.14	4.14	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	94.35	11.73	7.46	1.60	2.13	0.53	0.53	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	65.94	7.50	4.29	3.22	2.14	0.00	0.54	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	61.77	6.32	7.02	2.11	1.40	0.70	1.40	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	53.34	4.71	9.41	2.35	3.92	0.78	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	71.19	5.27	11.86	2.64	2.64	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	51.78	4.93	3.29	0.82	1.64	1.64	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	26.84	5.80	2.90	2.90	0.73	0.00	0.00	0.73	2.18
CD19+ B Cells, donor3	11705-123B4	44.93	3.53	1.01	3.03	1.51	1.01	0.50	0.00	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	168.09	11.72	11.72	3.23	14.95	2.42	2.02	0.00	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	122.64	16.78	9.99	3.99	14.38	2.00	1.20	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	34.14	4.02	4.02	2.01	3.01	1.00	0.00	0.00	4.02
CD34+ Progenitors, donor2	11625-122B5	43.26	4.49	6.74	5.62	2.25	1.12	0.56	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	22.92	1.88	4.13	2.63	0.75	0.38	0.00	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	30.21	4.06	6.09	2.48	1.35	0.45	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	66.06	6.07	9.64	3.93	3.93	0.00	1.43	0.00	2.14
CD4+ T Cells, donor2	11306-117C1	44.70	9.19	8.57	6.12	0.61	0.00	0.61	0.00	2.45
CD4+ T Cells, donor3	11382-118B5	53.68	5.18	6.40	3.05	3.05	0.30	0.30	0.00	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	65.60	3.32	6.89	3.32	1.02	0.26	0.51	0.00	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	57.95	3.37	4.94	4.27	0.67	0.00	0.67	0.00	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	55.19	2.87	6.61	2.87	0.29	0.00	0.00	0.00	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	66.85	7.59	5.69	3.32	0.95	0.47	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	75.85	11.24	6.32	4.21	2.81	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	52.74	9.89	9.89	9.89	6.59	0.00	3.30	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	51.74	2.89	5.93	3.03	0.87	0.14	0.58	0.00	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	35.93	3.05	3.90	2.03	0.68	0.17	0.00	0.00	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	37.24	3.06	3.87	3.06	1.13	0.32	0.00	0.00	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	62.76	7.17	10.76	4.48	3.14	0.45	0.45	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	74.42	5.59	5.59	3.49	1.75	0.00	1.05	0.00	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	87.56	7.92	6.16	3.96	4.84	0.44	0.44	0.00	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	50.60	6.75	6.32	3.79	1.26	0.84	1.26	0.00	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	32.62	3.32	3.12	1.04	0.83	0.00	0.21	0.00	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	33.08	3.01	1.34	3.01	1.67	0.33	0.67	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	67.44	10.61	7.61	5.44	1.09	0.00	0.54	0.00	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	77.18	12.86	15.54	6.97	1.07	0.54	1.61	0.00	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	77.11	1.79	8.97	7.17	1.79	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	70.65	6.86	6.12	3.71	2.41	0.74	0.93	0.00	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	47.22	3.90	5.20	3.90	2.38	0.22	0.65	0.00	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	55.69	3.36	4.83	3.15	2.73	0.21	0.63	0.00	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	58.14	7.08	7.58	3.54	1.52	0.00	0.51	0.00	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	55.02	5.63	11.26	3.90	3.03	0.87	0.43	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	80.19	9.59	12.20	5.23	3.05	1.31	2.61	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	82.64	9.90	11.38	7.42	2.97	0.00	0.99	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	76.62	5.54	5.54	6.46	1.85	0.00	1.85	0.00	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	71.19	2.79	13.96	2.79	0.00	0.00	0.00	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	103.57	11.91	14.40	6.92	1.66	0.55	0.55	0.00	3.32
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	115.33	10.55	15.71	7.85	2.70	0.49	0.74	0.00	3.93
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	101.64	6.16	15.40	7.70	4.62	0.00	1.54	0.00	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	87.02	9.31	12.18	6.09	1.79	1.43	0.72	0.00	3.94
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	94.18	12.46	11.08	6.92	5.54	0.00	0.00	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	76.28	6.55	8.84	2.95	4.26	0.33	1.31	0.00	1.31
CD8+ T Cells, donor2	11307-117C2	57.44	3.38	7.88	5.26	4.13	0.38	0.75	0.00	2.25
CD8+ T Cells, donor3	11383-118B6	65.39	7.32	10.60	5.30	3.28	0.00	0.50	0.25	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.47	2.52	0.46	1.38	0.46	0.69	0.46	0.00	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.74	2.16	0.96	0.48	0.24	0.72	1.20	0.00	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.67	1.92	0.82	0.55	1.09	0.27	0.55	0.00	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.91	1.80	1.80	2.10	0.30	0.60	0.30	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.64	1.44	0.48	1.92	0.72	0.96	0.24	0.00	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.00	2.27	0.45	1.36	0.45	0.45	1.14	0.00	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.78	2.39	1.30	1.96	0.87	0.43	0.87	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.53	2.11	1.84	2.11	0.26	0.53	1.05	0.00	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	16.18	3.75	2.11	1.64	1.41	1.17	0.70	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	11.77	2.42	1.51	3.32	0.60	0.91	0.00	0.00	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.33	2.61	2.03	2.03	0.58	0.29	0.29	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.92	4.00	1.07	1.60	0.27	0.00	0.80	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.38	5.25	3.50	0.44	2.19	0.44	0.88	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.12	6.38	1.37	2.28	2.28	1.37	0.91	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.93	4.48	1.49	2.24	2.24	1.49	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.64	1.80	1.80	2.52	1.08	0.36	0.00	0.00	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.93	4.03	0.58	3.74	1.15	0.29	0.29	0.00	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.19	0.47	2.12	2.59	0.71	0.47	0.24	0.00	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.63	2.85	1.58	1.90	0.63	1.58	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.99	3.38	2.15	3.69	1.54	0.31	0.92	0.00	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.50	3.21	1.60	1.60	0.32	0.32	0.32	0.00	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	12.62	1.91	1.91	2.68	0.38	1.15	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.46	1.97	2.76	1.58	0.79	0.79	0.39	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	3.03	0.76	3.78	1.51	0.76	1.51	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	38.54	12.04	6.42	3.21	3.21	1.61	4.01	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	35.67	8.39	1.40	2.10	5.60	1.40	2.10	0.00	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	31.05	11.02	4.01	2.00	3.01	0.00	1.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00	0.00	3.66	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	10.87	0.99	0.49	0.99	0.49	0.49	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	11.37	0.74	0.95	0.84	0.32	0.11	0.21	0.00	0.42
Chondrocyte - de diff, donor1	11261-116G1	16.64	2.08	0.00	1.39	0.00	0.35	0.00	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	8.53	0.36	1.07	1.07	0.36	0.36	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	8.65	0.57	0.91	0.23	0.11	0.23	0.23	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	10.74	0.00	0.90	0.00	0.00	0.00	0.00	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	6.87	1.21	1.21	1.21	0.00	0.81	0.00	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	17.79	2.64	1.03	1.38	0.11	0.11	0.34	0.00	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	9.62	1.07	0.86	2.14	0.00	0.00	0.64	0.00	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	12.21	2.21	1.42	0.97	0.00	0.27	0.44	0.00	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	27.33	4.40	3.48	2.11	0.55	0.92	1.28	1.83	0.55
Corneal Epithelial Cells, donor1	11526-119I5	4.39	0.66	0.00	0.00	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	0.00	0.00	0.00	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	3.58	0.26	0.00	0.00	0.00	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	37.97	2.97	1.16	1.32	0.17	0.83	0.33	0.00	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	39.74	3.47	1.26	0.95	0.63	0.95	0.63	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	3.45	3.45	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	22.03	1.84	0.54	0.65	0.11	0.32	0.22	0.00	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	38.61	9.22	29.04	7.52	10.93	0.00	3.07	0.00	4.10
Dendritic Cells - plasmacytoid, donor2	11309-117C4	43.09	7.83	27.42	16.97	26.77	0.00	0.00	0.00	5.88
Dendritic Cells - plasmacytoid, donor3	11385-118B8	50.81	6.78	37.26	14.52	19.84	0.00	1.45	0.00	9.19
Endothelial Cells - Aortic, donor0	11207-116A1	10.01	0.67	0.67	0.50	0.00	0.33	0.50	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	0.59	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	10.46	0.28	1.13	1.13	0.00	0.28	0.57	0.00	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	1.18	0.39	0.39	0.39	0.39	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	6.11	0.29	0.00	0.58	0.00	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	7.29	0.94	0.47	0.24	0.24	0.24	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	7.36	0.70	0.35	0.18	0.53	0.18	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.96	3.10	0.66	1.11	0.00	0.22	0.22	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.65	2.74	2.43	0.91	0.91	0.30	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	18.32	1.13	1.97	0.85	0.28	0.00	0.28	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	9.81	1.19	0.59	0.00	0.00	1.19	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	6.77	0.52	0.00	0.52	0.00	0.00	0.00	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	7.66	0.28	0.57	0.14	0.14	0.57	0.00	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	18.41	2.00	0.40	0.00	0.00	0.40	0.40	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	0.00	0.00	0.00	0.00	0.00	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	28.08	2.36	1.24	2.61	0.25	0.87	0.25	0.00	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	15.86	0.43	1.09	2.82	0.00	0.87	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	16.49	0.98	0.85	1.95	0.12	0.49	0.24	0.00	0.49
Endothelial Cells - Vein, donor1	11267-116G7	10.24	0.00	0.00	0.00	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	7.68	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.21	0.94	0.47	0.31	0.00	0.47	0.16	0.00	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	328.40	49.51	37.96	18.15	28.05	19.80	4.95	0.00	1.65
Eosinophils, donor3	12246-129H5	199.74	42.80	32.10	7.13	21.40	10.70	10.70	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	4.15	0.24	0.00	0.24	0.00	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	16.27	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.32	1.64	1.23	1.64	0.41	0.82	0.00	0.00	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.07	0.11	0.11	0.22	0.11	0.00	0.11	0.00	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.14	0.43	0.11	0.11	0.11	0.00	0.11	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.19	1.58	1.33	0.97	0.49	0.49	0.00	0.00	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.27	8.73	5.19	3.68	4.09	0.68	1.64	0.00	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	5.91	1.05	0.63	0.21	0.11	0.21	0.42	0.00	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	50.59	3.69	1.58	2.63	0.79	0.26	1.05	0.00	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.96	0.66	0.33	1.00	0.00	0.00	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	8.62	0.45	0.91	1.81	0.45	0.00	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	13.64	0.00	0.00	0.00	0.00	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.05	0.32	0.47	0.47	0.16	0.16	0.00	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	21.82	2.12	3.33	2.73	0.61	0.30	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	20.05	1.40	1.02	1.40	0.13	0.89	0.00	0.00	0.51
Fibroblast - Cardiac, donor6	11460-119B2	14.10	2.12	0.76	1.52	0.61	0.15	0.30	0.00	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.59	0.80	0.27	0.67	0.00	0.13	0.27	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	0.43	0.43	0.86	0.00	0.00	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	11.72	0.00	2.93	1.46	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	6.69	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	20.18	3.22	1.19	1.36	0.34	0.34	0.68	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	7.51	1.17	2.35	1.64	0.00	0.00	0.23	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	7.08	1.42	0.00	0.47	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	6.53	0.48	0.85	1.09	0.36	0.00	0.24	0.00	0.60
Fibroblast - Dermal, donor4	11450-119A1	9.95	1.13	1.13	1.81	0.11	0.23	0.11	0.00	0.34
Fibroblast - Dermal, donor5	11454-119A5	14.13	2.09	1.57	2.79	0.17	0.17	0.35	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	17.22	1.95	0.81	0.97	0.32	0.00	0.49	0.00	0.97
Fibroblast - Gingival, donor1	11237-116D4	21.03	0.62	1.67	2.29	0.42	0.42	0.21	0.00	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.55	1.83	1.05	1.83	0.26	0.26	0.00	0.00	1.05
Fibroblast - Gingival, donor2	11318-117D4	13.44	1.32	1.32	0.79	0.26	0.13	0.40	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	16.82	1.06	1.26	0.97	0.39	0.39	0.19	0.00	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	0.00	2.08	0.00	0.00	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.92	1.23	0.70	0.53	0.35	0.35	0.18	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	15.90	1.56	1.71	0.62	0.94	0.62	0.16	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	11.63	1.35	1.08	1.49	0.54	0.41	0.00	0.00	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.94	1.06	0.35	0.35	0.00	0.35	0.35	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	13.45	1.17	0.58	1.61	0.88	0.00	0.15	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	14.04	2.32	0.95	0.95	0.27	0.27	0.14	0.00	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	12.40	1.54	1.54	1.21	0.55	0.22	0.55	0.00	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	26.56	2.20	0.73	1.91	1.17	0.29	0.59	0.00	0.59
Fibroblast - Lung, donor1	11270-116H1	6.80	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	5.97	1.49	4.48	1.49	0.00	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	8.23	1.27	0.21	1.06	0.00	0.42	0.21	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	2.50	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.40	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	6.50	0.81	0.00	0.41	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	16.88	0.78	1.16	2.33	0.97	0.39	0.00	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.99	2.28	0.61	1.97	0.76	0.15	0.15	0.00	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.78	1.22	2.75	1.22	1.53	0.92	0.00	0.00	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	13.74	0.00	0.76	2.29	1.53	0.38	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11.34	1.89	0.54	1.35	0.00	0.27	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.24	0.93	0.93	1.62	0.12	0.46	0.23	0.00	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.07	1.22	1.66	0.55	0.11	0.22	0.33	0.00	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.91	0.20	0.00	0.61	0.00	0.00	0.81	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	3.34	0.67	0.67	0.00	0.00	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.12	0.79	0.40	0.79	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	54.77	3.37	2.58	2.58	0.99	1.79	0.99	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.58	1.07	1.78	0.53	0.00	0.18	0.36	0.00	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.58	2.17	1.38	1.58	0.59	0.00	0.99	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	31.29	4.21	0.90	3.01	0.30	1.20	1.50	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	21.48	3.02	1.84	2.48	0.54	0.22	0.00	0.00	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	54.92	4.56	3.04	3.80	0.51	2.02	0.25	0.00	1.01
Fibroblast - skin normal, donor1	11553-120C5	13.13	1.64	1.15	1.64	0.49	0.33	0.66	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	44.71	3.21	3.41	3.21	0.20	1.00	0.40	0.00	1.00
Fibroblast - skin normal, donor2	11561-120D4	16.88	1.41	1.11	1.11	0.40	0.90	0.20	0.00	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	59.54	5.14	3.63	3.02	1.51	2.42	2.12	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.63	2.15	1.49	1.33	0.83	0.33	0.75	0.00	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	34.19	2.74	2.91	0.85	1.20	0.51	0.17	0.00	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	32.51	3.61	1.97	2.30	0.33	1.31	0.66	0.00	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.85	1.38	1.49	0.85	0.11	0.32	0.11	0.00	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	14.17	1.52	1.01	0.84	0.51	0.00	0.51	0.00	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	2.98	1.25	0.78	0.16	0.16	0.16	0.16	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.92	1.74	2.61	0.00	2.61	2.61	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	17.68	2.60	2.25	1.21	2.60	1.04	0.52	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	18.48	1.04	2.60	0.78	1.56	0.26	0.52	0.00	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	17.89	2.30	1.53	0.51	3.58	0.26	0.00	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	10.72	1.53	0.00	0.00	0.77	0.00	0.77	0.00	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	0.64	0.00	0.64	0.64	0.00	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	20.25	2.00	2.00	2.00	0.86	1.14	0.00	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	26.20	2.48	0.55	0.55	0.00	0.28	0.00	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	21.69	2.28	1.60	1.60	0.91	1.37	0.00	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	17.44	1.39	0.40	0.79	0.20	0.59	0.59	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	18.50	1.32	0.53	0.79	0.00	1.59	0.26	0.00	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.48	0.98	0.98	1.30	1.30	0.33	0.00	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	18.57	0.88	0.00	1.33	0.88	0.88	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	13.71	1.13	0.28	0.85	0.57	0.71	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	17.24	0.86	0.37	0.62	0.62	0.49	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	12.09	0.81	0.27	0.54	0.54	0.54	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	11.77	0.74	0.74	1.49	0.00	0.25	0.00	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	13.57	0.55	0.42	0.69	0.42	0.42	0.00	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	9.56	0.81	0.00	0.81	0.61	0.20	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.38	0.68	0.68	1.60	0.00	0.00	0.23	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	15.94	1.00	0.75	0.25	0.37	0.25	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.70	0.66	0.22	0.87	0.00	0.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	12.41	0.30	0.89	0.00	0.59	0.30	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	17.96	0.32	0.79	0.95	0.00	0.16	0.16	0.00	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.85	1.56	0.45	0.67	0.22	0.45	0.45	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.91	1.21	0.60	0.81	0.20	0.81	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	15.95	1.19	0.17	0.34	0.00	0.68	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.00	0.53	1.15	1.42	0.53	0.71	0.35	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.50	1.98	0.62	0.62	0.10	0.52	0.10	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.91	0.68	1.02	0.68	0.00	0.17	0.17	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	14.50	0.89	0.44	0.44	0.33	0.33	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.30	1.50	1.00	1.08	0.50	1.00	0.17	0.00	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.97	1.02	0.20	0.41	0.41	0.61	0.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.92	1.44	0.62	0.21	0.41	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.10	0.69	0.12	0.35	0.12	0.12	0.23	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	16.01	0.17	0.33	0.17	0.33	0.50	0.17	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.67	0.44	0.22	0.00	0.22	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.57	1.11	0.74	0.49	0.12	0.00	0.00	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.48	0.65	0.81	0.32	0.32	0.65	0.00	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	18.28	1.92	0.64	1.28	0.32	0.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.77	0.85	0.09	0.09	0.28	0.28	0.09	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	12.65	0.47	0.32	0.95	0.00	0.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	11.25	0.61	0.00	0.00	0.30	0.30	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.03	0.94	0.21	0.31	0.31	0.31	0.21	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	12.95	0.88	0.00	1.10	0.22	0.22	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	13.19	1.12	0.28	0.00	0.00	0.84	0.56	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.98	1.02	0.93	0.19	0.00	0.65	0.00	0.00	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	11.23	0.80	0.27	0.00	0.27	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.92	0.61	0.31	0.46	0.31	0.61	0.31	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.03	0.78	0.52	0.52	0.26	0.52	0.00	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.45	0.54	0.00	1.08	0.00	0.54	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.01	0.37	0.37	1.29	0.18	0.74	0.18	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.89	1.97	1.10	0.44	0.22	0.44	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	13.88	0.99	0.00	0.99	0.00	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	11.87	0.53	0.79	1.19	0.13	0.40	0.26	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	12.31	1.21	0.61	0.61	0.20	0.00	0.00	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	22.62	2.80	0.25	1.52	0.00	0.51	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	29.46	1.59	1.00	1.79	0.60	1.79	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	18.18	0.62	0.15	0.62	0.15	0.92	0.15	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	22.50	0.61	0.61	1.23	1.02	1.02	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	11.89	0.63	0.94	0.63	0.00	1.25	0.31	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.02	0.00	0.28	0.00	0.28	0.00	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.98	0.92	1.38	1.38	0.00	1.38	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	0.00	0.00	0.00	0.00	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	20.89	0.39	1.16	1.16	0.00	0.39	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	17.65	0.00	0.00	1.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	24.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	17.58	0.65	0.98	0.98	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	23.06	1.24	1.24	2.06	0.41	1.65	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.06	0.84	0.84	0.56	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	18.63	0.65	0.98	1.63	0.00	0.98	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	22.65	2.52	0.00	0.84	0.00	0.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.13	0.64	0.95	1.27	0.00	0.64	0.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	12.23	0.00	0.68	0.68	0.00	1.02	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	0.00	0.00	2.09	0.00	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.90	0.57	1.15	1.15	0.57	0.57	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.43	0.59	0.59	0.30	0.59	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	23.72	1.69	0.00	1.69	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	16.98	1.24	1.24	0.41	0.00	0.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	18.87	0.46	0.69	0.46	0.00	0.92	0.00	0.00	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.53	0.38	0.38	0.77	1.15	0.38	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	15.32	0.33	0.33	0.65	0.00	0.65	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	20.07	0.00	1.34	1.34	0.67	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	23.12	1.54	0.77	0.77	0.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.69	1.37	2.05	0.00	1.03	1.71	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.82	1.42	1.89	1.89	0.47	0.47	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	19.92	1.21	0.00	0.00	0.00	0.00	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	22.89	1.02	0.51	1.02	0.51	0.00	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	18.75	1.20	1.20	0.80	0.00	0.00	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	28.12	0.49	1.48	0.49	0.49	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	30.69	1.18	1.18	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	21.59	0.58	0.00	1.17	0.58	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.94	0.44	1.32	0.44	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	14.41	0.00	1.70	0.00	0.00	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	27.46	1.19	0.60	0.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	0.97	1.46	2.43	1.46	0.97	0.00	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	1.14	0.00	0.00	0.00	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	6.24	0.42	0.42	0.00	0.83	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	4.50	0.00	1.12	1.12	0.00	0.00	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.83	0.95	0.63	0.63	0.32	0.32	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.01	0.42	0.42	0.84	0.00	0.00	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.63	0.93	0.70	0.58	0.58	0.46	0.35	0.00	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.00	1.35	0.84	1.01	1.52	0.17	0.17	0.00	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.65	0.68	0.23	0.46	0.91	0.23	0.46	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.17	1.31	0.55	0.77	1.09	0.77	0.22	0.00	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.75	0.86	0.86	0.86	0.21	0.43	0.00	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.49	0.86	0.65	0.86	0.43	0.65	0.00	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.34	1.12	1.00	0.25	0.87	0.25	0.00	0.00	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.78	0.86	0.86	0.51	1.03	0.51	0.00	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.89	0.32	0.96	0.96	0.96	0.32	0.00	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.60	0.43	0.00	0.00	0.00	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	2.64	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	3.88	0.71	0.35	0.35	0.00	0.00	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	5.77	0.52	0.70	1.05	0.35	0.17	0.00	0.00	0.52
Hepatocyte, donor1	11523-119I2	53.27	2.42	1.21	1.21	1.21	1.21	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	19.39	2.15	0.00	3.23	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	34.97	1.23	1.23	1.23	1.23	0.00	0.61	0.00	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	32.63	7.18	7.18	2.61	4.57	0.00	0.00	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	28.49	1.05	1.75	1.05	1.57	0.35	0.17	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.64	1.10	0.82	0.55	0.00	0.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	66.86	6.37	0.00	3.18	3.18	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	1.38	2.77	2.77	0.00	2.77	1.38	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	2.56	0.00	7.69	0.00	2.56	2.56	0.00	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	4.57	4.57	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	3.25	1.62	0.00	0.00	3.25	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	5.00	0.00	0.00	1.67	0.00	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	0.00	2.65	2.65	2.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	46.56	4.43	1.11	1.11	0.00	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	0.00	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	42.83	4.41	0.63	1.26	0.63	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	34.03	1.55	1.55	1.55	0.00	1.55	1.55	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	46.51	1.94	2.58	2.58	0.00	0.00	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	54.74	4.83	3.22	1.61	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.89	1.63	1.63	4.07	0.81	1.63	1.63	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	39.04	4.20	0.84	1.68	0.42	1.26	1.26	0.00	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	46.61	4.02	0.00	0.80	1.61	3.21	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	18.47	2.77	4.62	0.92	1.85	1.85	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	32.10	2.83	1.42	0.00	0.94	1.42	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	27.21	4.53	0.00	1.81	0.91	1.81	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	0.00	14.74	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	60.26	3.23	0.00	2.15	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	2.54	0.00	2.54	0.00	2.54	0.00	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	42.09	2.55	0.64	2.55	0.00	1.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	3.65	1.82	3.65	0.00	1.82	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	48.56	5.71	1.43	1.43	0.71	2.14	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	6.64	3.32	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	24.69	1.23	0.00	0.62	0.00	0.93	0.00	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	0.00	0.00	0.00	0.00	0.00	1.76	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	0.00	3.14	15.72	0.00	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	62.58	4.17	1.39	1.39	0.00	2.09	2.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	2.21	2.21	0.00	0.00	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	0.00	0.00	3.24	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	27.03	3.49	1.74	1.74	0.87	0.00	0.87	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	0.00	0.00	4.50	0.00	0.00	0.00	0.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	0.00	3.48	0.00	0.00	0.00	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	0.00	2.13	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	40.18	1.39	0.00	2.77	0.00	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	5.70	0.00	0.00	0.00	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	29.45	3.68	1.84	1.84	0.00	1.84	0.92	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	23.26	1.06	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	10.85	0.98	0.33	0.90	2.12	0.16	0.08	0.00	0.24
Keratinocyte - epidermal, donor2	11349-117G8	4.10	1.17	0.00	0.00	1.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	11.55	0.57	0.19	0.38	0.76	0.19	0.19	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	18.84	2.84	1.36	1.36	1.02	0.23	0.11	0.00	0.23
Keratocytes, donor1	11527-119I6	4.81	0.34	0.34	0.00	0.34	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	3.52	0.00	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	9.29	0.40	0.00	0.00	0.20	0.00	0.40	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	0.00	2.20	2.20	8.79	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	5.39	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	11.53	1.27	0.46	0.81	0.23	0.35	0.12	0.00	0.35
Lens Epithelial Cells, donor3	11690-122I7	11.10	0.91	1.51	0.61	0.30	0.00	0.20	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.43	0.24	1.19	0.36	0.12	0.47	0.36	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.37	0.00	0.84	0.56	0.00	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.70	0.79	0.47	0.94	0.00	0.16	0.16	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.45	0.00	0.54	1.61	0.54	0.00	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.84	1.26	0.32	1.58	0.00	0.95	0.00	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.34	0.32	0.32	0.32	0.22	0.32	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	1.23	0.82	0.82	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.54	0.25	0.25	0.00	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.36	0.56	0.28	0.70	0.14	0.14	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.54	0.00	1.58	0.00	0.00	0.40	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.23	0.19	0.58	0.19	0.00	0.00	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.78	0.19	0.19	0.19	0.19	0.19	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.71	0.35	1.39	0.35	0.35	0.35	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.01	0.72	0.00	0.24	0.00	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.71	0.27	0.69	0.55	0.27	0.14	0.14	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.93	0.92	0.00	0.31	0.62	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	0.62	0.00	0.62	0.00	0.00	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.84	0.91	0.18	0.00	0.00	0.00	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.58	0.33	0.00	0.66	0.00	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.34	1.17	0.88	0.29	0.00	0.00	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.48	0.50	0.25	0.50	0.00	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	0.48	1.45	1.94	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.12	0.00	0.27	1.08	0.54	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.51	0.61	1.06	0.45	0.00	0.61	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.15	2.59	0.00	1.04	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.28	1.05	0.42	1.05	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.56	0.30	0.15	0.30	0.00	0.45	0.15	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	0.69	0.00	0.00	0.69	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.08	0.38	0.75	0.38	0.19	0.56	0.00	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.29	0.11	0.11	0.42	0.00	0.32	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	5.81	0.00	0.97	1.45	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.95	0.33	0.33	0.00	0.33	0.00	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.21	0.25	0.50	0.25	0.12	0.12	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.85	0.74	0.37	0.74	0.00	1.11	0.74	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.17	0.74	0.74	0.49	0.49	0.00	0.25	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.26	0.14	0.14	0.14	0.00	0.14	0.41	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.36	1.29	1.61	1.61	0.32	0.00	0.00	0.00	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.70	1.52	1.22	0.91	0.30	0.30	0.30	0.00	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.26	0.42	0.84	0.56	0.28	0.14	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.98	0.71	1.07	0.71	0.71	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	0.48	0.48	0.97	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.89	0.47	0.16	0.16	0.00	0.00	0.31	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.80	0.36	1.07	0.72	0.00	0.36	0.00	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.86	0.65	0.65	0.00	0.00	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.47	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	9.53	0.74	1.24	0.99	0.25	0.50	0.25	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	0.26	0.51	0.26	0.26	0.26	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.28	0.00	0.30	0.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	2.27	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	0.77	1.53	0.00	1.53	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	13.36	2.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	12.27	1.27	0.42	0.00	2.12	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.29	2.11	0.00	0.70	0.70	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	0.00	0.00	0.00	0.00	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.24	1.03	0.52	0.52	0.00	0.52	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	1.19	0.00	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.35	1.58	0.00	1.13	0.45	0.00	0.00	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.47	1.16	0.00	0.58	2.62	1.16	0.00	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.45	0.45	0.00	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.53	2.44	0.54	1.08	0.81	0.54	0.41	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.19	0.51	0.51	0.00	0.00	0.51	0.51	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.23	1.41	0.71	1.06	0.71	0.71	1.06	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	14.66	2.00	0.00	0.00	0.00	1.33	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.73	3.57	0.51	0.00	1.53	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	11.47	1.07	0.80	0.27	1.60	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.28	2.08	0.94	0.19	0.94	0.76	0.94	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.95	2.45	0.00	1.23	1.23	1.84	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	19.57	3.26	3.26	0.00	1.63	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.70	1.87	0.62	0.83	1.04	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.77	0.56	0.56	0.84	2.24	0.28	0.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	12.36	2.06	1.03	0.00	0.00	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.52	1.45	0.87	1.45	2.90	1.16	0.29	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.35	0.30	0.60	0.30	1.49	0.60	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	17.15	0.55	0.55	0.55	0.00	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.38	1.41	0.35	0.71	1.77	1.06	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.12	1.11	0.74	1.48	1.48	1.11	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	4.61	0.00	1.15	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	17.27	2.69	1.15	1.15	0.00	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	3.40	0.57	0.57	1.70	1.13	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	5.74	3.28	0.82	3.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.91	1.36	0.45	0.45	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	0.72	1.44	0.00	0.00	2.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	12.70	1.49	0.75	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.24	1.49	0.37	0.74	0.37	1.11	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.80	1.72	0.00	0.43	0.00	0.43	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	0.00	0.00	1.71	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.99	3.00	0.67	0.33	1.33	0.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	3.62	0.00	0.60	1.21	0.00	0.00	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	15.64	1.42	1.42	0.71	1.42	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	21.31	3.78	0.00	0.00	0.34	0.00	0.34	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.08	2.68	0.00	1.61	1.07	0.00	0.54	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.83	2.69	0.67	1.35	0.00	0.00	0.00	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.41	1.11	0.74	0.00	1.11	0.74	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	8.14	1.16	2.33	3.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	3.17	0.00	1.06	0.00	1.06	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.41	1.60	0.40	1.60	0.00	0.40	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	4.36	0.73	1.45	0.00	0.73	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	17.63	0.77	0.77	0.00	2.30	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	3.45	0.00	0.00	0.99	0.49	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	0.94	0.94	2.82	0.94	0.00	0.94	0.00	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.62	0.50	0.50	0.00	0.50	0.50	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.81	2.25	0.00	0.00	1.80	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	11.13	1.78	0.45	0.00	0.89	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	13.29	2.35	0.78	0.78	1.56	1.17	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.85	0.66	0.00	0.00	0.66	0.66	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.61	3.63	1.56	0.00	0.52	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	13.13	0.88	1.75	0.00	1.31	0.88	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.95	1.12	0.00	0.00	0.56	0.56	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.46	1.32	0.88	0.44	0.00	0.88	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.43	2.70	0.39	0.39	1.16	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	9.11	4.05	0.00	0.00	0.51	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.50	0.00	0.96	0.48	0.00	1.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.34	0.80	0.40	0.80	1.19	1.19	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	2.43	0.00	1.82	0.61	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	2.08	0.69	2.08	0.00	1.38	0.00	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.20	1.90	1.90	2.28	1.14	0.38	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.98	1.55	1.03	0.00	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	2.42	1.21	0.60	0.60	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.68	0.95	0.63	0.00	1.58	0.63	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.19	3.20	0.53	0.00	2.67	2.13	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	17.24	2.30	0.57	0.57	0.57	0.00	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.08	3.09	0.51	0.51	1.03	0.51	0.51	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.93	2.83	0.00	0.71	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	15.89	1.70	1.70	0.57	0.57	3.40	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	16.22	2.50	0.42	1.25	0.00	0.00	0.83	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.09	0.78	0.78	0.00	0.78	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.70	1.25	1.25	1.25	1.25	0.42	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.84	2.32	0.46	0.46	1.39	0.93	0.46	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.72	2.01	0.00	1.34	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.64	1.60	1.60	2.14	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.55	2.42	0.40	0.81	1.21	0.40	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	0.92	0.00	1.84	0.00	0.92	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	20.45	2.67	0.00	1.78	2.67	1.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.81	2.85	0.57	0.57	1.71	2.28	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	22.24	0.00	0.00	2.30	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	19.70	2.74	1.09	0.55	1.09	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.36	0.89	0.00	1.78	1.34	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	18.72	2.34	0.26	0.52	1.04	0.52	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.87	1.99	0.66	0.00	0.66	0.66	0.00	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	38.52	2.51	0.91	1.60	0.00	0.68	0.46	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	22.02	1.84	2.02	1.84	0.00	0.55	0.37	0.00	0.55
Macrophage - monocyte derived, donor3	11389-118C3	23.33	1.31	1.97	1.18	0.13	0.79	0.13	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.68	2.66	0.00	0.53	1.59	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	17.43	2.69	1.58	0.63	1.11	0.16	0.16	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	15.01	1.81	0.42	0.42	2.08	0.56	0.69	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	16.14	1.89	1.20	1.10	1.20	0.60	0.50	0.00	0.30
Mammary Epithelial Cell, donor2	11350-117G9	15.06	0.87	0.58	1.16	1.45	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	5.24	0.50	0.25	0.50	0.25	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	53.56	2.03	2.71	2.71	0.68	2.03	0.00	0.00	4.75
Mast cell, donor1	11563-120D6	39.58	2.92	1.62	1.19	0.32	1.19	0.54	0.00	0.65
Mast cell, donor2	11565-120D8	69.54	4.16	2.97	2.97	1.19	2.67	0.59	0.00	2.08
Mast cell, donor3	11566-120D9	64.61	3.83	2.48	2.93	0.68	3.38	0.45	0.00	1.13
Mast cell, donor4	11567-120E1	75.17	4.08	4.61	3.01	0.35	2.13	0.89	0.00	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	53.01	3.88	2.11	2.88	0.22	1.77	1.00	0.00	1.66
Mast cell, expanded and stimulated, donor8	11942-126A7	51.95	2.92	0.58	2.92	0.00	1.75	0.58	0.00	1.75
Mast cell, expanded, donor5	11939-126A4	41.07	1.95	1.15	1.49	0.00	1.38	0.23	0.11	0.34
Mast cell, expanded, donor8	11941-126A6	66.28	1.84	0.84	1.00	0.33	2.34	0.00	0.00	1.00
Melanocyte - dark, donor1	11502-119F8	11.44	0.80	0.99	0.80	0.20	0.99	0.10	0.00	0.30
Melanocyte - dark, donor2	11582-120F7	9.69	0.35	1.04	1.04	0.00	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	19.78	0.65	0.22	0.65	0.22	0.65	0.14	0.00	0.22
Melanocyte - light, donor1	11274-116H5	10.58	0.47	0.00	0.47	0.24	0.71	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	9.55	0.00	0.68	0.68	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	0.87	0.00	0.00	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	9.37	0.73	0.10	0.21	0.00	0.10	0.10	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	11.03	1.08	0.00	0.00	0.27	0.81	0.27	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	10.45	0.54	0.54	0.54	0.27	0.27	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	8.93	0.87	0.37	1.24	0.00	0.12	0.00	0.00	0.12
Meningeal Cells, donor2	11573-120E7	6.16	0.00	0.00	0.44	0.00	0.44	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	10.43	0.73	1.06	1.55	0.16	0.24	0.98	0.00	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	12.83	0.86	0.86	0.57	0.00	0.86	0.00	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.06	2.42	1.01	1.61	0.50	0.10	0.50	0.00	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	6.46	1.44	1.44	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.80	2.33	0.64	1.69	0.42	0.21	0.21	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.04	1.01	0.50	1.51	0.00	0.00	0.00	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.05	1.32	0.66	0.00	0.00	0.00	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	0.00	0.00	0.73	0.73	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	3.68	0.00	0.41	0.41	0.00	0.00	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	14.27	2.35	1.25	1.52	0.14	0.00	0.28	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.83	0.37	0.00	1.12	0.00	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.68	1.05	1.18	0.66	0.13	0.26	0.13	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.86	0.59	0.00	0.00	0.00	0.59	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	3.20	1.28	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	8.51	1.42	1.42	0.35	0.00	0.00	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.64	1.56	1.56	1.56	0.00	0.31	0.00	0.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	3.63	0.00	0.00	0.00	0.00	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	9.81	3.45	1.33	0.80	0.27	0.00	0.27	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	7.01	0.00	0.00	1.00	0.50	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	7.08	1.73	1.30	0.58	0.43	0.07	0.22	0.00	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	33.76	4.05	6.75	4.05	0.00	0.00	0.00	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	21.43	1.48	0.99	2.22	0.25	0.25	0.00	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	19.73	2.06	1.47	0.59	0.29	0.59	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	0.00	6.91	3.46	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.88	1.24	1.24	1.55	0.31	0.31	0.00	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	13.48	1.24	1.24	0.83	0.00	0.41	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	2.32	4.63	2.32	0.00	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	19.52	1.00	1.00	0.25	0.25	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	22.34	2.33	0.93	3.26	0.00	0.93	0.00	0.00	2.33
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.07	1.22	1.22	0.81	0.20	0.81	0.00	0.00	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	19.80	0.79	0.79	0.79	0.00	1.58	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.50	0.38	0.76	1.14	0.38	0.00	0.00	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	0.00	1.32	0.00	0.00	0.00	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.70	0.64	0.85	0.42	0.21	0.21	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	0.00	2.76	1.84	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.24	0.60	0.89	0.00	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	0.00	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.28	1.00	0.75	1.00	0.25	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.22	0.48	0.71	1.19	0.24	0.71	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.74	0.55	1.11	1.11	0.00	0.00	0.00	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.60	0.00	0.69	0.23	0.00	0.00	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.04	1.05	0.63	0.42	0.21	0.42	0.21	0.00	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.97	0.61	0.00	0.20	0.20	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.08	0.43	0.21	0.64	0.21	0.64	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	16.23	1.33	0.67	1.56	0.22	0.44	0.22	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.91	0.66	0.22	0.22	0.22	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	2.53	1.01	1.52	0.51	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	0.00	0.00	1.66	0.00	3.31	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.78	1.63	0.27	0.27	0.27	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	15.88	1.18	0.59	0.88	0.88	0.59	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	0.00	1.09	0.00	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	0.96	0.00	0.48	0.00	0.00	0.00	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.21	2.00	2.00	1.20	0.40	0.00	0.40	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	0.00	1.37	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10.01	0.50	0.50	0.00	0.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	0.00	2.04	2.04	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	13.14	0.88	1.31	1.75	0.44	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	22.07	1.10	3.31	6.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.65	0.00	5.12	1.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	15.37	0.50	0.25	1.74	0.25	0.25	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.18	1.39	2.78	2.78	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	2.21	4.42	4.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.99	0.68	0.34	0.34	0.00	0.34	0.68	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.94	0.44	3.50	3.06	0.00	1.31	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.98	1.07	1.07	1.42	0.36	0.00	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.47	0.56	0.00	0.84	0.00	1.12	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	25.77	0.83	0.42	1.66	0.83	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	23.89	1.17	3.50	2.33	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.07	0.30	1.51	0.90	0.30	0.00	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	20.45	2.09	0.83	1.67	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	25.86	1.85	1.85	0.00	0.92	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	31.30	2.28	1.14	2.85	0.57	0.57	0.57	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.96	1.52	1.24	1.52	0.41	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.81	0.52	0.78	1.04	0.00	1.04	0.52	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	20.16	2.57	2.57	3.00	0.00	2.14	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	16.51	0.00	1.91	3.81	0.64	0.64	0.00	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.35	0.00	2.67	0.80	0.27	1.33	0.00	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	23.05	2.39	2.10	0.60	0.60	0.90	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.27	0.28	0.85	0.99	0.14	0.42	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.01	0.64	1.59	0.96	0.00	0.00	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	33.61	2.65	2.65	1.77	0.44	1.33	0.66	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.96	0.76	1.90	0.76	0.76	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	1.42	1.99	1.70	0.85	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	20.40	1.72	2.70	0.98	1.23	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.94	0.65	1.30	3.26	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	20.58	0.88	2.35	0.88	0.29	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.35	0.58	1.73	2.02	0.58	1.73	0.29	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.97	0.82	1.65	2.47	0.41	0.82	0.00	0.00	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	19.06	0.60	0.30	1.79	0.60	0.60	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	17.74	0.33	0.99	0.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	1.05	3.16	0.00	0.00	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.54	1.58	0.99	0.99	0.20	1.19	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	17.70	1.86	0.00	0.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.53	1.88	0.38	0.38	0.00	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.45	0.80	0.53	0.80	0.27	0.27	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	20.02	0.34	1.02	0.34	0.11	0.11	0.00	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	0.00	0.74	0.00	0.00	0.00	0.74	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.59	0.00	0.37	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	0.00	3.11	1.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.88	0.53	0.00	0.00	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	0.42	0.42	0.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	24.51	4.09	0.00	0.00	1.36	2.72	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.00	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	0.81	0.00	0.00	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	1.51	1.51	0.00	0.00	0.00	0.00	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	114.20	22.84	5.71	0.00	17.13	0.00	0.00	0.00	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	61.99	3.26	3.26	0.00	3.26	9.79	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	4.75	0.00	0.00	0.00	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.02	1.94	1.29	1.29	1.08	0.22	0.86	0.00	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.54	2.09	1.05	1.05	0.00	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	0.67	0.00	0.67	0.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.01	0.42	0.00	0.83	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.55	0.95	0.95	1.52	0.00	0.19	0.00	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	14.36	0.00	1.60	0.00	0.00	0.00	0.00	0.00	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	0.00	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	1.84	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.02	0.42	0.42	1.26	0.00	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.04	0.23	0.70	1.39	0.46	0.00	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.30	0.81	0.00	1.08	0.00	0.00	0.00	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.61	0.63	0.00	0.84	0.21	0.21	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	0.00	0.00	22.27	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	0.50	0.00	0.00	0.00	0.00	0.00	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.04	0.27	0.81	0.27	0.00	0.00	0.00	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.03	0.23	0.91	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.04	1.31	0.82	0.33	0.00	0.16	0.33	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	12.21	1.46	1.09	1.09	0.18	0.00	0.18	0.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	14.11	0.33	0.33	0.33	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.99	0.65	0.16	0.98	0.16	0.33	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.88	1.23	1.41	0.53	0.00	0.18	0.35	0.00	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	1.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.82	2.30	0.00	1.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.71	0.96	1.93	1.29	0.32	0.00	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.55	1.72	1.38	0.69	1.03	0.00	0.00	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	13.37	2.23	1.11	1.78	0.22	0.45	0.22	0.00	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	0.85	0.00	2.12	0.00	0.42	0.00	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.31	0.47	0.95	1.42	0.00	0.00	0.00	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.44	1.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	9.03	9.03	0.00	0.00	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	8.00	0.67	1.67	1.00	0.00	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	0.00	0.90	1.35	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	0.40	0.00	0.79	0.00	0.79	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	8.32	0.38	0.38	0.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.52	0.00	0.65	0.98	0.33	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.59	1.31	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.47	0.90	1.36	0.90	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	1.76	0.00	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	0.66	0.00	1.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	0.50	0.00	0.50	0.00	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	2.68	0.77	0.00	0.38	0.00	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.05	1.81	1.21	0.30	0.00	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.50	0.88	1.77	0.66	0.00	0.22	0.22	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	3.39	0.00	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	5.11	5.11	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	11.58	1.83	0.61	0.00	0.00	0.00	0.00	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.35	1.26	0.31	0.31	0.00	0.00	0.00	0.00	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.47	1.51	0.30	1.21	0.00	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	0.00	1.13	1.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	10.31	1.61	0.87	1.24	0.25	0.25	0.12	0.00	0.25
Myoblast, donor2	11322-117D8	13.62	0.58	0.77	1.15	0.19	0.19	0.38	0.00	0.58
Myoblast, donor3	11398-118D3	14.29	2.02	1.18	0.67	0.34	0.17	0.17	0.00	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	21.01	0.44	2.19	0.73	1.46	0.15	0.29	0.00	0.44
Natural Killer Cells, donor1	11230-116C6	89.49	7.07	5.23	6.46	4.00	1.54	0.31	0.00	1.85
Natural Killer Cells, donor2	11311-117C6	50.66	5.43	6.63	4.22	2.11	1.51	0.60	0.00	0.60
Natural Killer Cells, donor3	11387-118C1	57.24	4.05	6.63	3.87	2.02	0.92	0.92	0.00	1.10
Neural stem cells, donor1	11275-116H6	17.42	2.54	1.09	0.73	0.00	0.73	0.73	0.00	0.73
Neural stem cells, donor2	11352-117H2	32.74	1.93	1.93	1.93	1.93	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	11.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.14
Neurons, donor2	11574-120E8	14.31	3.30	0.44	1.32	0.00	0.22	0.22	0.00	0.88
Neurons, donor3	11655-122E8	9.87	1.64	0.00	0.00	0.82	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	291.39	38.98	38.05	10.21	24.13	6.50	5.57	0.00	2.78
Neutrophils, donor2	11314-117C9	182.63	11.60	23.19	5.80	26.09	8.70	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	315.81	57.42	45.81	11.61	33.60	9.77	6.72	0.00	4.89
Nucleus Pulposus Cell, donor1	11252-116F1	21.73	1.78	1.42	1.31	0.00	0.12	0.24	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	9.44	0.33	0.33	0.33	0.00	0.33	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	8.82	0.60	0.60	1.00	0.00	0.20	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	10.87	0.83	0.69	1.10	0.28	0.14	0.00	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	12.59	0.87	1.01	0.58	0.87	0.14	0.14	0.00	0.29
Olfactory epithelial cells, donor3	11935-125I9	8.97	1.02	0.68	0.79	0.57	0.34	0.34	0.00	0.57
Olfactory epithelial cells, donor4	11936-126A1	15.19	1.85	0.49	1.36	0.19	0.10	0.29	0.00	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	9.03	2.41	1.81	1.20	0.00	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.53	1.28	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	4.57	0.00	1.14	1.14	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	0.00	0.62	1.24	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.28	0.39	0.78	0.20	0.00	0.00	0.00	0.00	0.20
Osteoblast, donor2	11354-117H4	12.64	0.70	1.40	1.40	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	10.49	1.07	0.53	0.71	0.53	0.00	0.00	0.00	0.36
Pancreatic stromal cells, donor1	11249-116E7	16.43	1.26	1.26	1.68	0.84	0.42	0.25	0.00	0.42
Pericytes, donor1	11491-119E6	3.23	0.78	0.11	0.22	0.00	0.11	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	6.34	0.45	0.23	0.23	0.00	0.23	0.45	0.00	0.23
Pericytes, donor3	11652-122E5	4.48	0.81	0.00	0.41	0.00	0.00	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	13.34	1.24	0.68	0.79	0.11	0.23	0.68	0.00	0.00
Perineurial Cells, donor2	11579-120F4	16.29	2.48	1.01	1.01	0.00	0.00	0.09	0.00	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	86.38	5.10	7.33	3.51	2.87	0.64	0.64	0.00	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	40.40	3.67	4.16	1.71	1.22	0.73	0.49	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	46.46	3.88	4.40	2.46	1.81	1.55	0.91	0.00	0.65
Placental Epithelial Cells, donor1	11278-116H9	4.30	0.00	0.72	0.48	1.43	0.00	0.24	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	6.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.30	0.79	0.20	0.20	0.00	0.20	0.00	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.22	0.32	0.63	0.32	0.00	0.00	0.63	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	10.32	1.31	1.13	0.56	0.56	0.38	0.38	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	32.63	3.92	3.13	3.13	0.78	0.26	0.52	0.00	1.17
Preadipocyte - breast, donor2	11328-117E5	8.78	0.68	0.45	0.90	0.00	0.23	0.23	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	17.05	2.34	1.70	2.66	0.21	0.85	0.32	0.00	0.53
Preadipocyte - omental, donor2	11329-117E6	17.46	2.62	1.31	2.62	0.00	0.44	0.00	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	8.88	1.43	1.86	1.72	0.86	0.00	0.00	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	8.86	0.00	0.00	0.98	0.98	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	7.99	1.54	0.61	0.92	0.31	0.31	0.61	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	10.09	0.35	0.71	1.42	0.00	0.35	0.18	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	8.85	0.85	0.68	0.17	0.34	0.00	0.34	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	14.34	1.77	1.02	1.49	0.28	0.09	0.19	0.09	0.65
Preadipocyte - visceral, donor2	11357-117H7	7.82	0.46	0.46	1.84	0.46	0.00	0.00	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	7.00	1.04	1.04	0.94	0.21	0.42	0.00	0.00	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.33	1.06	0.91	0.91	1.06	1.36	0.15	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	10.16	0.95	0.54	0.14	0.81	0.00	0.27	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	8.94	0.80	0.37	0.12	0.49	0.06	0.24	0.00	0.12
Prostate Stromal Cells, donor1	11254-116F3	11.16	1.37	1.14	1.14	0.34	0.34	0.68	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	8.61	1.26	1.26	0.72	0.36	0.18	0.54	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	7.72	0.73	0.94	0.31	0.10	0.00	0.31	0.00	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	1.82	0.73	0.36	0.00	0.00	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	9.84	1.59	0.76	1.18	0.14	0.07	0.28	0.00	0.35
Renal Epithelial Cells, donor1	11517-119H5	3.04	0.51	0.00	1.01	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	0.00	0.71	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	12.28	1.27	1.80	1.59	0.53	0.11	0.21	0.00	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	3.40	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.18	0.54	0.40	0.54	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.32	0.89	0.89	0.22	0.22	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.96	0.66	0.00	0.22	0.44	0.00	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.02	0.63	0.00	0.00	0.00	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.94	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	5.37	0.54	0.54	0.81	0.00	0.00	0.27	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.11	0.00	0.42	1.27	0.00	0.00	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.28	0.58	0.58	0.19	0.00	0.00	0.00	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	8.82	0.52	0.00	0.78	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.11	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.79	1.51	0.25	0.50	0.00	0.25	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.97	6.15	4.28	1.60	1.34	1.34	1.34	0.00	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	0.89	0.00	0.00	0.89	1.79	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.87	2.20	0.00	0.00	0.00	1.65	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	33.06	0.58	1.16	1.16	0.58	0.58	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	28.74	1.69	1.04	1.95	0.39	1.43	0.13	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	18.27	1.19	1.19	0.70	0.20	0.60	0.10	0.00	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	27.44	1.45	0.56	1.45	0.11	0.89	0.45	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	27.29	1.24	1.61	0.62	0.12	1.49	0.12	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	16.67	1.63	0.47	0.12	0.12	0.70	0.35	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	24.50	2.31	1.62	1.16	0.00	1.85	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.49	1.37	1.37	0.82	0.00	0.96	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.57	0.61	0.76	0.61	0.15	0.61	0.45	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	33.51	2.15	2.33	2.15	0.54	1.08	0.18	0.00	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	20.66	1.00	0.29	1.15	0.29	1.43	0.14	0.00	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.56	0.86	1.07	1.07	0.21	0.97	0.21	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	24.56	1.55	1.11	0.89	0.22	0.89	0.22	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.28	1.15	1.15	1.34	0.00	0.76	0.00	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	18.07	1.21	0.75	0.93	0.37	1.02	0.09	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	34.57	1.32	1.13	1.69	0.38	0.75	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.56	1.19	1.06	1.19	0.13	0.40	0.27	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	18.40	1.17	0.68	0.78	0.68	0.49	0.19	0.00	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.48	0.95	1.34	0.76	0.38	1.34	0.19	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	19.97	1.17	1.17	1.07	0.64	1.28	0.21	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	18.22	1.68	0.84	0.00	0.00	0.56	0.00	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	18.80	0.85	1.37	1.03	0.51	1.71	0.34	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	22.61	1.28	0.91	0.55	0.18	1.09	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	15.57	0.74	0.86	0.98	0.12	0.49	0.12	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	23.37	1.75	0.54	1.34	0.27	1.07	0.13	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	18.40	0.94	1.65	1.42	0.00	0.71	0.00	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	15.87	0.60	0.79	0.79	0.20	0.60	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.94	1.17	1.40	0.47	0.47	1.17	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	17.63	0.41	0.83	1.24	0.00	1.45	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.02	0.22	0.44	1.33	0.00	1.11	0.44	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.07	1.04	0.84	1.25	0.21	0.63	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.48	0.54	1.08	1.48	0.00	0.40	0.13	0.00	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	21.29	1.36	0.85	1.36	0.51	0.68	0.17	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.79	1.16	0.96	1.74	0.00	0.58	0.00	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	24.42	1.55	1.03	1.03	0.17	0.69	0.17	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.95	1.23	0.96	0.82	0.00	1.65	0.27	0.00	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	27.91	0.99	1.64	1.81	0.00	0.82	0.33	0.00	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	24.71	0.68	1.02	1.36	0.00	0.85	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.46	0.59	1.33	0.44	0.30	0.74	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	23.99	1.07	1.33	1.87	0.27	0.53	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	20.05	0.41	0.55	0.83	0.14	1.24	0.14	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	20.48	0.71	0.48	1.19	0.48	1.67	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.01	0.81	1.01	1.61	0.40	1.01	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	19.87	1.22	1.13	0.94	0.00	1.41	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	17.82	0.35	0.35	0.35	0.35	0.70	0.00	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.25	1.51	1.21	0.60	0.30	0.60	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.62	1.35	0.37	1.35	0.00	1.10	0.00	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	85.58	4.37	2.33	2.77	1.02	2.91	0.29	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.64	0.61	1.22	0.00	0.00	1.22	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	17.18	1.21	0.90	0.30	0.30	2.41	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	25.33	1.36	0.90	0.90	0.23	0.45	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	35.35	0.90	0.90	1.50	0.00	1.80	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	35.30	1.06	1.06	0.94	0.12	2.24	0.00	0.00	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	27.32	1.92	0.85	1.07	0.43	0.85	0.00	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	42.07	1.20	0.60	2.40	0.00	0.60	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	4.89	0.56	0.00	0.38	0.00	0.38	0.00	0.00	0.38
Schwann Cells, donor2	11578-120F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	6.57	0.66	0.22	0.88	0.00	0.00	0.22	0.00	0.44
Sebocyte, donor1	11220-116B5	12.60	1.64	1.10	0.00	1.10	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	4.14	0.92	0.00	0.46	1.38	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	3.09	0.00	0.21	0.21	0.00	0.00	0.21	0.00	0.21
Sertoli Cells, donor1	11255-116F4	16.57	1.66	1.66	1.66	3.31	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	0.00	2.82	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	13.55	1.32	0.44	0.62	0.00	0.18	0.26	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	4.34	1.45	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	9.20	0.84	3.34	0.00	0.00	0.84	0.00	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	10.68	1.57	0.94	0.63	0.16	0.47	0.31	0.00	0.47
Skeletal Muscle Cells, donor5	11455-119A6	9.81	0.59	0.59	1.49	0.15	0.15	0.15	0.00	0.45
Skeletal Muscle Cells, donor6	11459-119B1	10.62	0.92	1.08	1.39	0.00	0.62	0.15	0.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	25.20	3.15	1.76	3.02	0.38	0.38	0.50	0.00	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	13.13	1.57	1.43	0.86	0.00	0.00	0.00	0.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	12.40	1.69	1.09	1.29	0.30	0.20	0.40	0.00	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.13	2.36	0.84	0.42	0.08	0.25	0.42	0.00	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	6.51	0.00	0.00	0.72	0.00	0.00	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.72	0.28	0.14	0.41	0.00	0.00	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	42.98	0.00	2.69	2.69	5.37	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.89	0.58	0.43	0.00	0.00	0.14	0.00	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	96.51	17.18	6.54	6.54	3.27	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	2.47	0.65	0.39	0.65	0.26	0.00	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	13.34	2.09	0.83	0.97	1.67	0.42	0.56	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	11.11	1.13	0.84	0.56	0.56	0.14	0.14	0.00	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	96.21	9.52	8.67	4.86	3.17	2.54	1.27	0.00	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	9.52	1.42	0.60	0.60	0.97	0.22	0.15	0.00	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	2.16	0.62	0.31	1.54	0.00	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	27.12	4.67	2.67	2.89	0.67	0.44	0.89	0.00	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	4.70	0.59	1.18	1.18	0.00	0.00	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.51	1.33	0.66	0.00	0.22	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.73	0.39	0.00	0.39	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	9.27	1.55	0.00	0.77	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.72	0.80	0.93	0.40	0.27	0.27	0.13	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.54	0.66	1.11	0.66	0.22	0.00	0.00	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.11	1.79	2.43	1.92	0.77	0.77	0.26	0.00	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.00	0.65	1.95	0.65	0.33	0.00	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.40	2.36	1.18	1.77	0.59	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.53	0.71	1.14	0.85	0.43	0.43	0.43	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	12.79	1.22	0.30	0.30	0.30	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	13.64	1.52	0.25	1.01	1.01	0.25	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.72	0.95	0.95	0.00	0.00	0.00	0.00	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	13.57	0.74	1.03	0.59	0.00	0.15	0.59	0.00	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.04	1.08	0.22	0.22	0.00	0.22	0.22	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	11.44	0.73	0.84	0.94	0.10	0.21	0.10	0.00	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.49	0.31	0.62	0.15	0.00	0.15	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	4.31	1.08	0.00	1.08	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.67	0.30	0.60	0.00	0.30	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	0.00	0.00	0.00	0.34	0.00	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.91	1.65	1.65	1.65	0.24	0.08	0.31	0.00	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.36	1.71	1.11	1.61	0.10	0.10	0.40	0.00	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	10.69	1.82	1.59	0.23	0.46	0.68	0.00	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	0.00	1.21	0.00	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.57	0.26	1.06	1.32	0.26	0.53	0.26	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	18.91	1.46	0.80	2.00	0.27	0.80	0.13	0.00	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.14	1.25	0.75	0.63	0.00	0.50	0.25	0.00	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	9.13	1.01	0.51	0.00	0.25	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.93	1.81	1.66	0.60	0.15	0.00	0.15	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	4.50	0.75	0.75	0.75	0.75	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	8.37	2.33	0.47	0.93	0.00	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	4.04	0.50	1.01	0.00	0.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.07	0.94	1.25	1.25	0.31	0.31	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.06	0.00	0.29	0.29	0.00	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	13.33	0.92	1.58	1.42	0.33	0.17	0.17	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.61	1.40	0.93	2.80	0.00	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.89	0.29	0.29	0.43	0.14	0.00	0.00	0.00	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	3.82	1.02	0.51	0.51	0.00	0.25	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3.38	0.94	0.75	0.38	0.00	0.00	0.00	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	11.18	1.82	1.12	0.84	0.14	0.00	0.42	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.80	0.75	0.92	0.92	0.08	0.00	0.50	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	0.00	0.95	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.63	1.71	0.73	0.73	0.49	0.00	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.94	3.54	1.55	1.77	0.44	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.78	0.29	2.34	1.17	0.00	0.29	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.05	1.17	0.58	0.97	0.00	0.00	0.19	0.00	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.11	0.26	0.26	1.32	0.00	0.53	0.26	0.00	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.53	1.86	0.74	0.74	0.00	0.00	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.94	3.23	0.72	1.44	0.00	0.72	1.80	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.67	0.85	0.85	0.85	0.00	0.00	0.28	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.24	0.79	0.39	0.79	0.00	0.00	1.18	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	9.90	1.27	1.02	1.02	0.51	0.25	0.00	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	15.97	0.40	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	0.84	0.84	0.84	0.00	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	15.58	0.46	0.92	1.38	0.00	0.00	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	11.61	0.84	1.51	1.35	0.17	0.17	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	9.05	0.17	0.67	0.50	0.34	0.00	0.34	0.00	0.50
Synoviocyte, donor3	11440-118H9	12.51	1.56	0.67	1.56	0.22	0.22	0.45	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	4.65	0.36	0.36	0.71	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	0.00	3.96	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.79	0.23	0.23	0.46	0.23	0.00	0.00	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	8.75	0.79	0.36	1.00	0.43	0.36	0.07	0.00	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	3.48	0.77	0.39	0.39	0.77	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.01	0.57	0.00	0.57	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	42.07	8.00	3.44	2.21	1.23	0.98	0.98	0.00	0.49
Urethra, donor2	10319-105A4	52.15	3.60	8.99	5.40	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2.39	0.27	0.27	0.00	0.00	0.27	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.01	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.21	0.46	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	10.70	1.11	2.01	1.78	0.22	0.00	0.45	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	170.84	24.02	48.05	8.01	18.69	4.45	5.34	0.00	7.12
Whole blood (ribopure), donor090309, donation2	12180-129A2	210.15	51.47	24.30	22.87	18.58	7.15	5.72	0.00	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	108.15	24.64	23.27	4.79	13.69	2.05	3.42	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	149.44	17.91	17.91	3.79	10.67	2.41	2.41	0.00	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	122.02	21.50	19.17	10.46	6.97	1.74	4.65	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	215.54	36.44	36.44	13.54	7.29	6.25	7.29	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	192.74	28.45	47.73	10.10	15.60	1.84	5.51	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	94.03	16.43	12.78	5.48	16.43	0.91	0.91	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	15.42	0.49	1.23	0.74	0.25	0.99	0.00	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	25.52	0.88	4.40	1.76	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	24.30	1.68	0.56	0.28	1.68	0.28	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	33.06	2.07	0.00	4.13	2.07	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	20.65	1.27	0.76	0.76	1.78	0.00	0.25	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	35.52	3.25	1.39	1.16	4.18	0.23	0.46	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	41.90	8.07	2.73	2.49	3.32	0.00	0.95	0.00	1.42
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	22.31	7.35	3.27	2.72	0.54	0.00	2.72	0.00	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	27.27	2.81	1.12	0.84	0.56	0.28	0.00	0.00	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	32.57	1.48	1.69	1.48	0.42	1.06	0.00	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	24.23	2.45	2.18	0.82	0.82	1.09	0.00	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	21.59	2.20	3.97	1.76	0.44	0.00	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.23	0.41	1.63	2.86	0.41	0.41	0.41	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	25.63	3.49	2.33	3.49	0.39	0.00	0.39	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.80	1.29	1.29	1.10	0.37	0.18	0.18	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	3.90	11.70	11.70	7.80	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	26.26	1.63	1.86	1.16	0.46	0.00	0.00	0.00	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	32.88	3.88	5.44	2.85	0.52	0.26	0.78	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	17.53	2.92	1.75	1.17	0.00	0.58	0.88	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.82	0.46	0.93	2.32	0.46	0.93	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	17.27	4.52	1.23	0.00	1.23	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.28	1.53	0.61	1.53	0.31	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	29.87	3.41	0.85	1.71	0.43	0.00	0.43	0.00	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	33.67	3.94	2.43	0.61	0.61	1.21	0.00	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	31.53	2.89	0.96	2.89	0.48	0.72	0.48	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	15.81	2.67	2.90	1.34	0.45	0.00	0.67	0.00	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	13.01	1.33	0.33	3.00	0.33	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	1.86	5.57	5.57	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	20.34	3.77	1.51	2.64	0.38	0.00	1.13	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	23.99	0.87	1.74	2.62	0.44	3.05	0.00	0.00	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	18.74	1.87	9.37	3.75	1.87	1.87	0.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	21.43	1.18	1.18	0.94	0.47	0.71	0.47	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	39.25	3.41	1.55	2.17	0.47	0.78	0.62	0.00	0.93
adipose, donor1	10184-103D4	34.60	1.76	2.93	1.17	0.59	0.00	0.00	0.00	1.17
adipose, donor2	10185-103D5	17.44	2.84	1.22	0.81	0.00	0.41	0.41	0.00	0.41
adipose, donor3	10186-103D6	20.15	1.91	0.54	0.82	0.00	0.54	0.00	0.00	0.00
adipose, donor4	10187-103D7	12.13	0.00	0.00	0.00	0.00	0.87	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	13.89	2.84	1.10	3.95	0.47	0.32	0.16	0.00	0.95
adrenal gland, adult, pool1	10081-102A9	10.91	0.00	3.64	3.64	0.00	3.64	3.64	0.00	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	24.28	4.54	3.74	3.60	2.13	0.53	0.53	0.00	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	17.86	1.43	0.36	0.36	0.36	0.00	0.36	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	25.74	2.78	2.09	1.16	6.49	1.62	0.46	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	22.65	0.00	0.00	1.01	0.00	0.34	0.34	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	20.03	3.83	2.06	2.36	1.47	0.29	0.29	0.00	0.59
amygdala - adult, donor10196	10167-103B5	36.76	7.11	1.19	1.19	1.19	1.19	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	38.93	5.47	2.64	1.62	0.41	1.42	1.01	0.00	0.61
amygdala, newborn, donor10223	10360-105E9	17.11	5.16	0.97	2.90	1.29	0.00	0.97	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	17.57	1.91	2.04	1.40	0.64	0.00	0.25	0.00	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	15.44	3.53	3.09	1.32	2.21	0.44	0.88	0.00	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	38.08	3.01	1.00	2.00	2.34	0.33	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	29.81	3.73	2.75	2.55	0.39	0.39	0.20	0.00	0.39
appendix, adult	10189-103D9	55.89	6.60	7.37	2.33	0.78	1.55	0.00	0.00	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	45.74	1.38	2.06	1.03	1.03	0.69	0.34	0.00	0.00
artery, adult	10190-103E1	25.82	1.36	1.36	0.00	2.72	5.43	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	33.90	1.45	1.88	1.59	1.59	1.30	0.14	0.00	0.43
b cell line:RPMI1788	10427-106D4	23.79	3.42	1.78	1.34	1.34	0.00	0.00	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.43	1.94	1.66	1.11	1.11	0.00	0.83	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.98	1.19	2.38	2.08	0.79	0.60	0.10	0.00	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	35.65	2.34	1.51	1.00	2.51	2.51	0.50	0.00	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.37	0.00	0.00	1.12	0.00	0.00	1.12	0.00	0.00
bladder, adult, pool1	10011-101C2	30.09	4.35	4.67	2.93	0.22	1.20	0.76	0.00	0.65
blood, adult, pool1	10053-101G8	35.43	0.00	2.21	0.00	6.64	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	22.27	1.71	0.00	0.00	0.86	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	44.54	2.02	3.37	2.02	0.00	2.70	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	25.63	3.08	0.00	2.05	1.03	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	24.05	3.67	0.89	1.00	0.45	0.56	0.67	0.00	0.67
brain, fetal, pool1	10085-102B4	16.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	19.82	1.32	3.63	2.31	4.63	1.32	0.33	0.00	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	27.59	2.87	1.25	1.25	3.12	1.25	0.37	0.00	0.50
breast, adult, donor1	10080-102A8	19.57	3.16	1.26	2.53	0.00	0.00	1.89	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.75	0.64	0.76	0.25	0.13	0.13	0.13	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.06	0.62	0.93	0.93	0.31	0.62	0.31	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.72	4.83	1.61	2.30	0.69	0.23	0.46	0.00	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.59	0.48	0.48	0.48	0.97	0.97	0.00	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	11.75	2.35	0.94	1.41	0.00	0.47	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	20.45	2.19	1.31	1.42	1.20	0.88	0.11	0.00	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	10.46	4.12	1.27	0.63	0.32	0.00	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	26.62	2.93	0.80	0.80	0.27	0.53	0.80	0.00	0.80
caudate nucleus - adult, donor10196	10177-103C6	26.48	5.76	3.45	2.30	0.00	0.00	2.30	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	33.97	6.36	4.18	1.84	0.67	0.33	1.17	0.00	1.00
caudate nucleus, adult, donor10258	10379-105H1	27.51	4.58	3.06	3.82	0.00	0.76	3.06	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	18.68	7.69	2.56	3.30	1.46	0.00	0.73	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	104.88	5.83	5.83	0.00	0.00	5.83	2.91	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	99.07	14.09	4.27	2.35	0.43	2.56	1.49	0.00	2.35
cerebellum, adult, pool1	10083-102B2	34.49	7.24	2.07	1.38	0.69	0.34	0.00	0.00	1.38
cerebellum, newborn, donor10223	10357-105E6	89.67	13.28	3.32	5.81	0.00	3.32	0.83	0.00	2.49
cerebral meninges, adult	10188-103D8	21.18	4.54	1.26	2.27	1.01	0.25	1.01	0.00	1.51
cerebrospinal fluid, donor2	10294-104G6	23.39	2.19	0.73	2.19	0.73	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	33.36	3.88	0.58	1.87	0.72	0.58	0.43	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	22.04	1.49	0.66	0.50	2.65	0.99	0.50	0.00	0.00
cervix, adult, pool1	10013-101C4	42.10	6.82	1.99	1.89	0.84	1.26	1.47	0.00	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.41	1.11	2.09	0.98	0.56	0.84	0.28	0.00	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	0.00	1.31	1.31	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	22.37	1.24	1.37	1.37	4.35	1.24	0.12	0.00	0.50
choriocarcinoma cell line:SCH	10785-110H2	22.06	1.48	0.37	0.49	0.74	0.62	0.25	0.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	15.65	0.71	0.24	0.71	0.71	0.24	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	13.68	1.71	1.99	0.85	1.14	1.42	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	19.39	1.19	1.19	0.70	0.80	0.30	0.10	0.00	0.30
chorionic membrane cells, donor3	12240-129G8	20.88	1.10	1.10	0.55	1.10	2.20	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	13.13	3.03	2.02	2.02	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	26.89	2.31	2.50	0.96	0.77	0.77	0.19	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.21	1.27	3.38	1.48	0.84	2.75	0.00	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	39.29	4.62	2.57	5.91	0.51	0.77	0.77	0.00	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	37.49	3.63	4.11	5.32	0.24	1.45	0.97	0.00	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	38.69	4.68	2.85	3.05	0.41	1.22	1.83	0.00	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	67.43	8.54	4.42	4.42	2.06	1.47	1.18	0.00	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	61.51	3.13	2.61	3.39	0.26	2.61	0.26	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	15.54	1.37	1.14	0.91	0.46	0.00	0.00	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	8.85	1.21	0.35	0.52	0.52	0.00	0.17	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	21.05	2.20	0.55	1.10	1.83	1.83	0.00	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	37.63	2.28	1.14	0.00	0.00	0.76	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	35.70	2.38	1.19	2.38	0.00	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	47.47	2.82	3.06	1.65	0.94	2.12	0.35	0.00	0.82
colon, fetal, donor1	10070-101I7	27.19	2.47	1.24	0.00	0.62	1.24	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	265.84	13.75	55.00	41.25	9.17	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	43.77	11.47	2.55	6.37	2.97	1.70	2.55	0.00	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	26.11	4.23	3.77	4.98	0.60	1.66	0.45	0.00	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	24.82	4.23	2.96	5.08	2.12	0.99	0.99	0.00	1.83
corpus callosum, adult, pool1	10042-101F6	50.97	10.39	1.00	1.00	0.44	1.22	1.88	0.00	1.11
cruciate ligament, donor2	10295-104G7	29.99	4.05	2.43	3.24	2.43	1.62	2.43	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	32.10	7.22	3.21	6.42	0.00	2.41	0.80	0.00	0.80
diencephalon, adult	10193-103E4	19.20	2.64	1.92	1.20	0.24	0.72	0.24	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.84	0.69	1.61	0.69	0.69	0.46	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.72	2.05	1.03	0.77	1.54	0.77	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.87	2.17	1.44	1.20	0.96	0.96	0.96	0.00	0.48
ductus deferens, adult	10196-103E7	36.88	1.99	1.99	3.49	1.50	2.99	1.99	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	41.77	1.44	5.76	1.44	0.00	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	51.50	4.41	3.68	2.21	0.00	1.47	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	43.28	5.62	1.82	1.57	1.16	0.99	1.07	0.08	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	60.85	4.89	3.78	4.00	6.66	2.22	0.44	0.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	36.97	2.72	0.72	1.86	1.29	0.14	0.43	0.00	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	15.42	0.00	0.00	0.62	0.62	0.00	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	8.17	1.82	0.30	0.00	0.61	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.95	0.93	0.31	0.62	0.00	0.62	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	11.82	0.00	1.31	2.63	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.80	2.35	0.67	1.34	1.34	0.67	0.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	17.04	2.17	0.18	1.27	0.36	0.91	0.18	0.00	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.33	0.96	0.64	0.64	0.80	0.00	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	67.47	4.78	4.11	2.11	6.56	1.56	0.33	0.00	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	23.43	1.43	1.54	1.10	2.42	0.77	0.44	0.00	0.33
epididymis, adult	10197-103E8	32.86	4.60	2.09	1.67	0.42	0.84	1.67	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	18.63	1.60	1.60	2.13	0.18	0.00	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.47	0.79	0.39	0.79	0.00	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	19.53	1.05	1.31	1.44	1.44	0.66	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.44	0.89	0.79	2.56	1.48	1.18	0.20	0.00	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	18.82	1.23	1.01	2.24	1.68	0.78	0.67	0.00	0.56
esophagus, adult, pool1	10015-101C6	29.84	3.93	1.70	2.02	0.96	1.06	0.42	0.00	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	27.30	2.76	0.75	1.25	0.00	0.13	0.50	0.13	0.63
eye - muscle inferior rectus, donor1	10272-104E2	57.95	0.00	4.83	0.00	0.00	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	33.67	4.21	2.10	2.10	0.00	4.21	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	34.23	0.00	1.49	5.95	0.00	0.00	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	45.86	2.29	1.15	1.15	0.00	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	7.29	2.91	1.46	2.91	0.00	1.46	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	21.86	4.32	2.03	1.53	0.25	1.27	0.25	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	10.90	1.28	0.38	0.90	0.26	0.38	0.13	0.00	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	17.33	1.42	1.42	3.56	0.00	0.00	0.24	0.00	0.47
frontal lobe, adult, pool1	10040-101F4	42.41	9.76	3.00	2.53	0.19	1.31	1.41	0.00	1.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	31.83	0.60	0.60	0.00	3.60	2.40	0.30	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	22.77	1.83	1.92	2.01	0.55	0.64	0.09	0.00	0.46
gall bladder, adult	10198-103E9	34.52	2.66	2.41	1.21	0.24	0.97	0.72	0.00	1.45
gamma delta positive T cells, donor1	11937-126A2	83.21	5.37	10.20	4.83	2.68	1.07	3.76	0.00	2.68
gamma delta positive T cells, donor2	11938-126A3	90.01	7.10	5.60	2.61	2.24	1.12	0.37	0.00	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.74	1.69	0.42	0.63	1.27	0.63	0.42	0.00	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	29.98	0.97	1.35	0.77	1.93	0.39	0.19	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	20.66	2.30	1.31	1.15	0.33	0.49	0.16	0.00	0.82
gastric cancer cell line:GSS	10560-108A2	21.05	4.58	2.75	1.83	0.92	1.83	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.33	1.83	2.06	0.46	1.14	0.69	0.46	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	9.29	1.72	0.69	0.57	0.34	0.11	0.46	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	32.33	4.48	1.96	3.64	1.40	0.98	0.42	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	17.46	0.50	2.24	2.99	2.49	0.75	0.00	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.45	1.27	0.53	0.74	0.63	0.32	0.32	0.00	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.41	0.98	0.98	0.70	0.42	0.28	0.28	0.00	0.42
glioblastoma cell line:T98G	10485-107A8	16.78	0.99	0.99	1.32	0.88	0.66	0.22	0.00	0.33
glioma cell line:GI-1	10413-106B8	19.92	1.76	1.17	0.00	1.46	0.88	0.00	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	24.78	2.92	1.46	0.73	0.00	0.00	2.19	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	57.36	10.50	2.44	1.22	0.00	1.71	1.46	0.00	1.71
globus pallidus, adult, donor10258	10367-105F7	17.80	5.48	1.37	5.48	1.37	0.00	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	17.05	7.46	0.53	1.07	0.00	0.00	2.13	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	161.51	26.92	26.92	29.37	0.00	2.45	2.45	0.00	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.28	0.64	0.32	1.60	0.96	0.32	0.32	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	21.12	0.00	0.92	0.46	0.92	0.00	0.00	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	20.12	2.74	1.83	2.29	0.00	0.00	0.46	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	19.32	0.00	0.00	0.64	0.64	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	23.00	0.00	0.00	1.44	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	19.20	1.37	0.69	2.06	0.69	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	20.97	4.41	1.10	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	13.79	2.01	0.29	1.15	0.86	0.86	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	36.47	6.58	2.69	2.69	0.60	1.49	1.20	0.00	1.79
heart - pulmonic valve, adult	10206-103F8	36.35	3.40	3.40	2.61	0.78	3.40	0.26	0.00	1.05
heart - tricuspid valve, adult	10207-103F9	49.96	9.16	5.00	0.83	0.00	0.83	1.67	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	14.69	1.84	0.82	0.82	0.41	1.22	0.61	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	18.74	1.70	1.28	2.13	0.43	1.28	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	26.22	2.53	2.30	2.07	0.00	3.45	0.46	0.00	0.69
heart, fetal, pool1	10046-101G1	46.31	4.52	2.16	2.05	0.82	6.16	1.13	0.00	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	7.40	1.85	1.54	0.93	0.00	0.31	0.31	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	29.73	1.19	2.38	8.32	0.00	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	24.53	1.77	1.77	2.54	0.99	1.22	0.33	0.00	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	25.00	1.46	1.94	1.94	1.21	2.31	0.12	0.00	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	29.51	1.21	2.53	2.02	0.71	1.92	0.10	0.00	1.11
hepatoma cell line:Li-7	10484-107A7	28.14	0.89	1.33	0.89	0.67	0.44	0.22	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	14.17	0.60	0.30	0.40	0.70	0.40	0.10	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	25.55	6.62	0.00	2.84	0.00	0.00	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	42.86	7.35	1.63	1.63	0.41	0.82	1.02	0.00	1.02
hippocampus, adult, donor10258	10374-105G5	24.40	6.97	3.49	5.98	0.00	0.50	1.00	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	15.51	3.88	1.76	1.41	0.70	0.35	0.70	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	28.69	0.61	1.22	0.61	0.00	1.22	0.00	0.00	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	12.17	0.98	0.59	0.79	0.39	1.18	0.39	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	15.23	0.76	0.51	1.27	0.25	0.51	0.25	0.00	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	19.74	1.13	0.56	0.56	0.00	0.00	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	20.92	1.81	0.00	0.77	0.00	0.26	0.26	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.78	1.14	1.14	1.52	0.00	0.76	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	28.90	1.46	1.75	0.88	0.88	1.17	0.29	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	26.93	2.80	0.22	0.43	0.22	0.86	0.65	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	15.43	1.25	0.00	1.67	0.42	0.42	0.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	14.44	0.95	0.24	1.18	0.47	1.42	0.24	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	15.43	1.77	0.32	0.64	0.16	0.96	0.32	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.24	2.69	0.00	2.69	0.00	0.00	0.67	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.18	1.10	0.00	1.88	0.63	0.63	0.16	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	15.72	0.98	0.49	0.49	0.49	0.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	14.84	0.00	1.75	0.87	0.87	1.75	0.00	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	20.62	1.91	1.15	1.53	0.00	0.95	0.00	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	19.62	2.62	1.31	0.44	0.44	1.74	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	23.99	2.50	0.50	1.50	0.50	0.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.77	5.09	0.75	1.13	0.19	0.57	0.38	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	23.65	1.36	1.36	1.82	0.00	0.45	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	22.24	2.82	1.25	0.63	0.31	0.31	0.31	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	13.55	0.49	0.33	0.16	0.16	0.33	0.65	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.32	1.74	1.16	0.58	0.29	0.29	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.55	1.49	0.90	0.90	0.00	0.90	0.00	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	13.30	1.29	0.18	0.18	0.92	0.92	0.00	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	14.83	1.14	0.57	1.43	0.29	0.29	0.00	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	22.87	1.63	1.63	1.63	0.41	1.22	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	10.91	1.76	1.06	1.76	0.00	0.00	0.00	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	13.94	0.95	0.63	1.90	0.00	0.63	0.32	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.04	1.21	0.30	0.91	0.00	0.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	16.03	0.52	1.03	1.03	1.03	1.55	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	10.63	3.98	1.99	0.00	1.33	0.00	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.42	2.57	0.51	1.80	0.00	0.26	0.26	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.85	1.28	0.26	0.77	0.00	0.77	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	19.69	0.76	2.27	2.27	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.75	1.68	1.01	1.01	0.67	0.34	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.28	0.24	0.24	1.45	0.24	0.72	0.00	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.27	0.00	0.00	1.78	0.00	0.00	0.00	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	15.61	1.46	0.98	1.95	1.95	1.46	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	16.81	0.92	0.31	0.61	0.31	0.31	0.31	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	87.84	0.00	3.25	6.51	0.00	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.48	3.31	0.99	1.65	0.00	1.99	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	25.72	1.09	0.00	1.64	0.55	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	18.46	1.45	1.09	1.09	0.36	0.36	0.36	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.93	4.27	1.07	1.07	0.71	0.71	0.36	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	0.00	1.19	0.00	0.00	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	18.96	1.90	0.54	0.95	0.14	1.22	0.00	0.00	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.43	1.35	0.27	0.54	0.00	0.54	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	23.49	0.97	3.63	0.73	0.48	1.70	0.24	0.00	0.48
immature langerhans cells, donor2	11905-125F6	16.63	1.58	3.17	0.00	6.34	2.38	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	38.89	10.41	2.27	2.56	0.95	0.76	1.70	0.00	1.70
keratoacanthoma cell line:HKA-1	10791-110H8	14.96	1.63	0.00	0.33	1.63	0.33	0.65	0.00	0.00
kidney, adult, pool1	10017-101C8	28.64	4.21	2.40	2.60	1.00	1.50	0.90	0.00	0.50
kidney, fetal, pool1	10045-101F9	40.25	5.80	1.63	1.70	0.35	1.06	1.41	0.00	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	37.07	3.55	3.41	3.55	0.71	1.70	0.99	0.00	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.08	0.69	0.00	0.83	0.00	0.28	0.14	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	15.05	2.39	0.73	0.92	1.47	0.37	0.55	0.00	0.37
left atrium, adult, donor1	10079-102A7	11.99	0.00	1.63	0.00	0.00	1.09	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	12.14	1.52	3.54	2.02	0.00	2.02	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	8.48	0.27	1.37	1.37	1.09	0.27	0.00	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	6.83	0.00	0.36	0.00	0.00	0.36	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	3.26	0.54	0.00	1.63	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	3.64	0.49	0.49	1.46	0.24	0.00	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	1.05	0.00	1.05	0.00	1.05	1.05	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	28.81	1.06	2.36	2.24	1.89	1.53	0.24	0.00	0.59
liposarcoma cell line:KMLS-1	10782-110G8	11.87	1.56	0.78	0.78	0.16	0.31	0.00	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	20.35	1.34	0.61	1.22	0.85	0.37	0.24	0.00	0.61
liver, adult, pool1	10018-101C9	27.87	2.76	1.78	0.97	0.81	1.13	0.32	0.00	0.81
liver, fetal, pool1	10086-102B5	21.64	1.88	1.88	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	23.77	5.69	0.87	1.02	0.29	0.29	1.17	0.00	0.87
locus coeruleus, adult, donor10252	10165-103B3	37.28	6.27	1.85	2.03	0.00	1.48	1.11	0.00	1.29
locus coeruleus, adult, donor10258	10375-105G6	20.31	4.80	1.13	1.69	0.00	0.56	0.85	0.00	1.13
locus coeruleus, newborn, donor10223	10362-105F2	24.40	7.15	0.84	1.68	0.00	0.42	0.84	0.00	2.10
lung adenocarcinoma cell line:A549	10499-107C4	9.13	1.25	0.55	0.97	0.28	0.28	0.00	0.00	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	20.68	2.07	0.69	0.69	0.00	1.38	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.45	0.79	0.66	0.66	0.92	1.05	0.00	0.00	0.26
lung, adult, pool1	10019-101D1	37.68	6.62	4.02	1.89	1.18	0.35	0.95	0.12	1.06
lung, fetal, donor1	10068-101I5	115.88	22.55	9.70	4.85	2.00	2.00	3.71	0.00	3.42
lung, right lower lobe, adult, donor1	10075-102A3	38.95	4.12	4.12	2.75	1.83	2.29	0.46	0.00	1.37
lymph node, adult, donor1	10077-102A5	26.98	3.79	4.73	0.47	0.95	0.47	0.47	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	11.84	0.44	1.32	2.41	1.10	0.00	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	24.15	2.11	2.26	0.60	3.77	0.60	0.00	0.15	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	25.48	1.70	1.70	0.85	7.65	0.00	0.00	0.00	1.70
mature adipocyte, donor1	12231-129F8	29.30	1.33	3.55	2.66	0.44	1.78	0.89	0.00	1.33
mature adipocyte, donor2	12232-129F9	37.15	4.77	2.08	2.08	0.21	1.45	0.00	0.00	0.42
mature adipocyte, donor3	12233-129G1	28.92	2.13	2.37	2.61	0.71	1.19	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	43.43	2.90	3.16	2.63	1.05	2.37	0.00	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	30.97	2.86	2.86	2.62	0.48	0.48	0.24	0.00	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	28.20	5.64	2.26	2.26	0.00	0.00	3.38	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	44.14	6.80	3.31	3.49	0.55	0.92	1.29	0.00	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	21.60	2.86	1.59	1.59	0.00	0.32	0.00	0.00	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	29.43	10.24	0.85	2.99	0.85	0.00	0.43	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	33.75	9.45	2.36	2.19	0.34	1.01	1.35	0.00	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	49.24	6.79	2.55	2.76	1.06	0.64	1.70	0.00	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	3.85	1.93	3.85	0.00	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	22.25	7.90	1.44	3.59	0.72	0.36	2.15	0.00	2.51
medulla oblongata - adult, donor10196	10174-103C3	27.26	7.14	1.95	1.95	0.65	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	41.33	4.64	1.55	1.08	0.46	1.55	0.93	0.00	0.77
medulla oblongata, adult, pool1	10038-101F2	36.90	6.94	1.14	2.04	0.57	1.55	1.22	0.00	1.06
medulla oblongata, newborn, donor10223	10361-105F1	25.00	7.29	2.08	1.74	0.35	0.00	1.74	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	31.66	1.33	0.66	1.77	1.55	0.89	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	13.69	0.37	1.47	1.22	0.49	0.24	0.00	0.00	0.61
melanoma cell line:COLO 679	10514-107E1	16.82	1.29	0.57	0.57	0.00	1.01	0.00	0.00	0.29
melanoma cell line:G-361	10465-106H6	19.55	1.09	0.27	0.81	0.00	0.27	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	7.42	1.09	0.72	0.90	0.00	0.00	0.00	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.03	3.52	1.76	0.88	0.88	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	17.11	2.33	0.26	0.52	0.52	0.52	0.52	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.21	0.77	1.84	0.46	0.46	0.15	0.15	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	13.09	0.55	0.55	1.09	0.73	0.36	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	0.83	1.66	1.66	0.83	0.00	0.83	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	9.27	0.56	0.98	1.26	0.56	0.28	0.14	0.00	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.24	0.19	0.58	0.39	0.58	0.39	0.00	0.00	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	1.39	3.47	1.39	0.69	0.00	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.33	1.37	1.72	1.03	0.17	0.17	0.17	0.00	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.81	1.73	0.81	1.04	0.12	0.00	0.00	0.00	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	8.36	1.06	1.06	1.46	0.93	0.27	0.13	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	7.97	0.95	0.68	1.08	0.14	0.27	0.14	0.00	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	11.24	1.56	1.42	1.00	0.57	0.14	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.11	0.66	1.32	1.98	0.00	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.38	0.83	0.83	0.69	0.00	0.14	0.00	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.47	0.00	0.70	0.70	0.35	0.35	0.70	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	9.80	0.82	1.02	2.04	1.22	0.00	0.20	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	13.66	2.16	1.80	1.44	1.08	0.00	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.45	0.72	1.76	0.93	0.52	0.00	0.31	0.00	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.54	1.82	1.14	0.68	0.46	0.00	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.85	0.84	1.68	2.52	0.84	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.91	1.20	1.05	0.60	0.15	0.00	0.30	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.20	0.88	1.31	0.96	0.88	0.35	0.18	0.00	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.15	1.84	1.10	0.37	0.00	0.00	0.37	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.45	2.00	1.14	2.29	0.00	0.86	0.00	0.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	12.21	1.68	1.26	0.84	0.00	0.00	0.00	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	0.46	0.46	1.37	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.46	0.26	1.02	0.00	0.26	0.26	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.47	1.31	1.31	0.26	0.00	0.26	0.26	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.39	0.31	0.31	0.92	0.31	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.47	0.94	0.24	1.18	0.00	0.00	0.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.51	0.68	0.00	0.68	0.68	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	3.54	2.36	0.79	1.18	0.00	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.02	0.46	0.00	1.39	0.00	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.65	0.29	0.00	1.44	0.00	0.00	0.29	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.48	1.12	0.89	0.45	0.22	0.22	0.22	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	10.34	0.72	0.72	0.72	0.48	0.24	0.24	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	17.60	0.00	0.73	0.00	1.47	0.73	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.07	0.34	1.01	0.67	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	0.41	1.23	0.00	0.00	0.00	0.00	0.00	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	11.60	1.29	0.86	0.00	0.00	0.00	0.86	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.34	1.62	1.62	0.97	0.65	0.32	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.66	1.07	0.53	2.13	0.00	0.00	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	0.00	0.82	0.82	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.00	1.17	0.78	0.39	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	0.00	0.99	0.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.30	0.00	1.78	1.19	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	7.31	1.22	0.00	2.44	0.00	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	1.27	0.00	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.35	2.41	2.76	1.38	0.00	0.00	0.00	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	0.00	0.00	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.96	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	0.79	0.00	0.79	0.00	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	0.00	1.18	0.00	0.00	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.29	0.94	0.62	0.62	0.31	0.00	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	0.00	1.34	0.00	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	1.18	1.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	5.14	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	12.39	2.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.84	0.99	0.99	0.00	0.99	0.49	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	0.00	1.12	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.63	1.27	0.64	0.64	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.66	0.40	0.00	0.00	0.00	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	0.00	2.18	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	1.27	0.00	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.35	0.00	0.00	1.82	0.00	0.61	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	0.82	0.82	0.82	0.00	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.91	1.19	0.20	0.60	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	6.81	0.65	0.00	0.00	0.32	0.00	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	1.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	31.72	4.64	2.32	0.00	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.83	1.18	1.42	2.60	0.71	0.24	0.24	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.60	1.16	1.16	0.70	0.46	0.23	0.00	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	0.00	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.73	1.03	0.72	0.62	0.82	0.10	0.21	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	9.53	0.68	0.68	0.68	0.00	0.68	0.23	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	9.29	0.73	0.98	0.49	0.24	0.00	0.49	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	13.06	0.89	1.55	1.55	1.77	0.44	0.22	0.00	0.44
mesothelioma cell line:Mero-82	10853-111F7	13.93	1.05	0.79	0.00	0.53	0.53	0.53	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	12.77	1.19	1.02	1.36	0.17	0.00	0.17	0.17	0.51
mesothelioma cell line:Mero-84	10855-111F9	7.84	1.52	0.51	0.76	0.51	0.00	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	5.80	1.04	0.00	0.41	0.21	0.00	0.41	0.00	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	5.14	0.83	0.33	0.66	0.17	0.00	0.33	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	9.05	1.81	0.36	0.90	0.36	0.54	0.36	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	14.01	1.02	0.51	1.88	0.51	0.34	0.51	0.00	0.34
mesothelioma cell line:NCI-H28	10845-111E8	13.49	0.76	1.02	1.53	0.25	0.25	0.25	0.00	0.00
mesothelioma cell line:No36	10857-111G2	10.11	1.30	0.65	0.65	0.33	0.65	0.98	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	12.73	2.17	1.08	0.81	1.63	0.00	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	27.83	3.07	3.26	3.84	0.96	0.96	0.96	0.00	1.34
migratory langerhans cells, donor2	11902-125F3	23.93	3.91	3.91	3.54	0.49	0.12	0.49	0.00	1.10
migratory langerhans cells, donor3	11903-125F4	34.10	1.62	6.46	2.15	0.72	0.18	0.00	0.00	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	28.73	1.96	1.63	0.98	0.33	0.33	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.81	0.85	0.42	0.64	0.00	0.64	0.00	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	16.82	1.38	1.38	2.53	1.84	0.92	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.80	2.47	2.66	1.33	1.71	0.95	0.38	0.00	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.98	4.80	2.59	0.37	0.55	0.55	0.00	0.00	0.92
myeloma cell line:PCM6	10474-106I6	21.55	1.98	0.79	0.79	0.79	0.79	0.59	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	25.87	0.00	1.01	1.52	0.00	1.01	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.95	0.59	0.39	1.18	0.39	0.39	0.39	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.59	1.23	0.67	0.56	0.78	0.00	0.11	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.18	1.10	0.96	0.96	0.81	0.15	0.22	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	14.35	3.86	1.66	1.10	0.55	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	30.83	4.14	2.53	2.07	1.38	0.46	0.92	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	22.64	2.43	4.12	2.06	1.31	1.12	0.37	0.00	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	21.72	2.53	1.48	1.27	0.63	0.21	1.05	0.00	0.63
neuroblastoma cell line:NH-12	10555-107I6	26.28	3.17	0.56	1.86	0.37	0.19	0.37	0.00	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.37	4.74	0.71	0.71	0.00	0.00	0.95	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	17.74	3.01	1.27	1.43	0.48	0.00	0.32	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	23.35	1.81	0.60	1.61	0.00	0.20	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.08	2.54	1.91	1.27	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	10.11	0.80	1.86	1.33	0.27	0.00	0.00	0.00	0.53
neutrophil PMN, donor1	12133-128D9	327.25	0.00	14.87	0.00	0.00	14.87	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	0.00	0.00	0.00	9.47	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	87.44	7.61	5.24	3.21	2.20	1.86	1.69	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	18.41	2.40	2.40	1.60	0.00	0.00	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	10.90	2.24	0.64	0.32	0.32	0.32	0.32	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	12.09	2.63	1.31	1.05	0.00	0.00	0.53	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	38.34	8.91	2.25	3.19	0.37	1.03	1.87	0.00	1.12
occipital cortex - adult, donor10196	10172-103C1	32.97	18.54	0.00	6.18	0.00	2.06	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	60.38	13.15	3.49	4.03	1.07	0.81	1.61	0.00	1.34
occipital cortex, newborn, donor10223	10355-105E4	24.75	10.92	1.46	3.64	0.73	0.36	1.46	0.00	1.09
occipital lobe, adult, donor1	10076-102A4	26.24	4.46	1.05	0.79	0.00	0.00	0.52	0.00	1.05
occipital lobe, fetal, donor1	10073-102A1	41.19	9.87	2.57	3.00	0.43	0.86	1.72	0.00	1.72
occipital pole, adult, pool1	10036-101E9	22.47	5.05	1.26	0.95	0.32	0.47	0.71	0.00	0.79
olfactory region, adult	10195-103E6	25.22	5.92	1.72	1.91	0.38	0.19	0.57	0.00	0.96
optic nerve, donor1	10277-104E7	44.02	8.00	2.00	4.00	0.00	2.00	0.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	20.50	1.48	1.14	0.68	2.51	0.91	0.11	0.00	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	39.29	5.50	0.55	0.41	0.69	0.41	1.24	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	5.42	1.02	0.34	0.00	0.34	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	15.25	0.81	0.81	0.92	1.62	0.35	0.12	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	13.23	2.35	1.76	0.29	0.88	1.18	0.59	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	2.80	2.80	2.80	1.87	1.87	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	64.04	8.69	4.03	2.33	2.76	0.85	1.91	0.00	1.27
ovary, adult, pool1	10020-101D2	26.55	5.85	2.01	1.83	0.26	0.26	0.61	0.00	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.28	1.65	1.10	2.57	0.18	0.18	0.73	0.00	0.00
pancreas, adult, donor1	10049-101G4	27.28	1.88	2.82	1.88	1.88	1.88	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.42	0.84	0.00	0.56	1.40	1.40	0.00	0.00	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	16.35	0.85	0.68	0.85	0.34	0.00	0.00	0.00	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	21.86	0.66	1.16	1.49	0.50	0.00	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	35.60	8.60	2.01	2.38	0.82	1.19	1.28	0.00	2.29
parietal cortex, adult, donor10258	10373-105G4	21.29	6.61	0.73	0.73	1.47	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	25.39	5.64	0.94	1.88	0.00	0.00	0.94	0.00	2.82
parietal lobe, adult, donor10252	10157-103A4	39.34	11.12	4.56	1.71	0.29	0.29	1.71	0.00	2.00
parietal lobe, adult, pool1	10034-101E7	35.95	8.20	2.03	2.91	0.26	0.88	0.44	0.00	1.59
parietal lobe, fetal, donor1	10072-101I9	46.55	16.49	2.91	3.88	0.97	0.00	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	18.69	11.22	1.50	2.24	0.75	0.00	1.87	0.00	3.74
parotid gland, adult	10199-103F1	24.67	0.00	3.08	0.62	2.47	0.62	0.62	0.00	0.00
penis, adult	10200-103F2	33.84	8.06	2.69	2.15	0.54	0.54	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	12.83	8.55	0.93	2.97	0.19	0.00	2.60	0.00	1.67
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.01	1.75	1.17	0.87	1.02	0.58	0.44	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	45.15	5.16	0.00	1.29	1.29	1.94	0.00	0.00	2.58
pineal gland, adult, donor10252	10160-103A7	92.39	9.48	8.29	5.33	0.00	1.78	0.00	0.00	4.15
pineal gland, adult, donor10258	10377-105G8	29.47	4.39	3.14	2.51	0.00	1.88	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	55.65	9.11	4.05	2.02	1.01	3.04	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	98.50	14.59	15.64	8.86	3.13	0.52	0.00	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	47.67	6.81	4.26	3.40	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	25.16	2.58	1.08	1.51	2.15	1.18	0.97	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	21.06	1.72	1.32	1.32	2.78	0.13	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	30.97	3.74	2.80	1.40	0.47	0.47	1.09	0.00	0.31
pons, adult, pool1	10033-101E6	36.32	6.80	2.50	1.46	0.69	1.81	0.86	0.09	1.12
postcentral gyrus, adult, pool1	10032-101E5	31.91	6.63	0.61	1.57	0.35	0.61	0.35	0.00	1.13
promyelocytes/myelocytes PMC, donor1	12132-128D8	117.12	0.00	16.73	12.55	2.09	2.09	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.48	0.87	1.31	1.02	1.89	0.44	0.15	0.00	0.58
prostate cancer cell line:PC-3	10439-106E7	18.51	2.36	1.09	3.09	1.63	0.36	0.91	0.00	0.54
prostate, adult, pool1	10022-101D4	33.37	4.35	2.81	2.90	0.45	1.18	0.45	0.00	0.73
putamen, adult, donor10196	10176-103C5	27.86	10.86	3.30	2.83	0.24	0.71	1.42	0.00	2.36
putamen, adult, donor10252	10152-102I8	35.29	3.92	1.96	5.88	1.96	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	2.19	0.00	1.09	0.00	2.19	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	21.75	7.49	2.42	1.93	0.48	0.24	1.21	0.00	0.72
putamen, newborn, donor10223	10365-105F5	25.49	10.50	0.00	1.50	0.00	0.75	1.50	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	36.37	2.04	0.29	2.62	2.91	0.58	0.00	0.00	0.87
rectum, fetal, donor1	10067-101I4	34.77	1.39	2.78	6.95	0.00	2.78	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	6.78	0.85	0.42	1.27	0.21	0.00	0.21	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	47.63	5.38	7.87	5.80	0.41	1.66	0.83	0.00	3.31
retina, adult, pool1	10030-101E3	42.24	5.57	2.88	1.69	0.70	0.50	0.80	0.00	0.99
retinoblastoma cell line:Y79	10475-106I7	39.75	3.12	2.60	2.08	0.52	0.78	0.26	0.00	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.43	1.35	0.61	0.25	0.12	1.23	0.12	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	32.06	3.09	0.28	1.97	0.00	0.00	1.41	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	19.70	3.03	5.30	1.52	0.76	0.76	0.00	0.00	2.27
salivary acinar cells, donor1	11771-123I7	15.86	1.29	0.81	0.97	0.65	0.16	0.16	0.00	0.16
salivary acinar cells, donor2	11772-123I8	20.52	1.79	1.38	0.96	1.10	0.14	0.28	0.00	0.14
salivary acinar cells, donor3	11773-123I9	31.78	0.66	1.99	3.31	0.66	0.66	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	50.90	5.72	1.72	1.72	1.14	1.14	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.19	2.78	1.10	1.69	0.08	0.08	0.08	0.00	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.87	2.12	1.29	1.18	0.12	0.12	0.00	0.00	0.47
seminal vesicle, adult	10201-103F3	31.74	2.65	1.06	4.76	1.06	3.70	0.00	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.82	1.21	1.21	1.21	1.70	0.49	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.55	1.01	0.50	0.75	0.25	0.50	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	10.04	0.00	1.00	0.00	1.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.85	2.55	1.21	0.54	1.07	0.67	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	25.75	1.11	0.55	1.11	0.66	0.99	0.22	0.00	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.03	0.65	1.16	1.68	0.13	1.42	0.00	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	53.20	2.84	3.55	3.55	0.71	6.38	1.42	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	31.54	3.60	3.12	4.20	0.36	2.28	0.00	0.00	0.48
skeletal muscle, fetal, donor1	10066-101I3	14.07	3.02	2.01	1.01	0.00	2.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	25.25	3.79	1.89	3.79	0.63	1.26	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	13.67	2.67	1.33	0.00	0.33	0.33	1.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	36.25	1.26	0.95	1.58	1.26	1.58	0.32	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	43.56	10.22	0.00	0.77	0.19	0.39	0.96	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	14.18	0.99	1.48	1.65	2.47	0.49	0.00	0.00	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	24.29	3.86	2.41	2.90	1.13	0.00	0.16	0.00	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	32.25	1.96	1.09	0.65	2.62	1.31	0.00	0.00	1.74
small intestine, adult, pool1	10024-101D6	66.89	3.46	3.58	2.27	1.31	3.58	0.12	0.00	1.31
small intestine, fetal, donor1	10064-101I1	21.38	1.72	0.74	0.98	0.74	0.74	0.00	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	22.57	1.03	0.51	0.51	2.05	0.00	0.51	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	33.60	3.88	1.81	2.58	1.03	1.55	1.03	0.00	1.03
somatostatinoma cell line:QGP-1	10781-110G7	24.39	0.27	2.14	1.34	1.61	0.80	0.00	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	23.86	2.98	0.92	1.84	0.92	0.92	0.00	0.00	1.61
spinal cord, adult, donor10252	10159-103A6	45.74	5.91	1.58	2.76	0.39	1.58	2.76	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	29.06	3.46	2.08	1.38	0.00	0.00	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	37.20	6.71	1.22	0.61	0.00	1.22	1.22	0.00	2.44
spinal cord, newborn, donor10223	10359-105E8	32.60	6.89	0.00	2.30	0.92	0.46	0.92	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	11.05	1.19	1.05	1.05	0.60	0.00	0.15	0.00	0.00
spleen, adult, pool1	10025-101D7	35.68	2.53	3.19	2.53	0.55	0.66	0.33	0.00	0.44
spleen, fetal, pool1	10044-101F8	49.58	7.87	4.05	1.35	1.27	1.03	0.56	0.00	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.73	1.14	1.45	1.14	0.62	0.21	0.00	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.22	1.14	1.71	1.14	1.33	1.33	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.27	2.45	1.40	0.35	1.05	0.70	0.00	0.00	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.56	0.39	0.39	0.39	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	23.19	1.58	2.25	1.13	0.90	0.79	0.45	0.00	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	12.28	0.85	0.85	0.42	0.42	0.85	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.31	0.42	3.81	0.85	0.00	1.69	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	49.13	3.20	1.07	7.48	0.00	0.00	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	42.73	1.71	6.27	1.71	2.28	1.14	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	44.86	6.02	1.87	0.83	0.21	0.62	1.87	0.00	0.83
substantia nigra, adult, donor10258	10371-105G2	27.93	4.14	0.52	2.07	0.00	0.00	1.55	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	28.26	4.95	0.71	1.41	0.00	0.00	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.76	4.59	1.83	2.98	0.69	0.69	0.92	0.00	0.69
temporal lobe, adult, pool1	10031-101E4	21.53	5.09	0.68	1.19	0.08	0.34	0.59	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	29.20	9.97	1.42	2.85	0.00	0.71	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	24.61	4.40	1.76	3.52	0.00	0.44	2.20	0.00	0.88
tenocyte, donor1	11763-123H8	9.08	0.35	1.75	0.70	0.00	0.00	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	8.77	1.53	1.91	1.53	0.00	0.00	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	10.75	0.37	0.74	1.11	0.37	0.00	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	16.66	0.85	0.85	1.02	1.36	0.68	0.51	0.00	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	16.03	0.92	0.31	0.46	0.00	0.92	0.15	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	13.17	0.62	0.77	1.24	0.46	0.46	0.15	0.00	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	18.92	1.78	2.03	1.40	3.81	0.63	0.25	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	26.85	2.27	0.38	1.89	0.76	0.76	0.38	0.00	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	25.63	1.42	4.04	3.71	11.67	0.87	0.11	0.00	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	12.38	0.65	0.33	0.65	0.98	0.33	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	21.47	4.40	0.86	1.40	0.86	0.32	0.54	10.63	0.21
testis, adult, pool2	10096-102C6	23.01	9.02	0.45	0.45	0.00	0.00	1.35	7.22	0.00
thalamus - adult, donor10196	10168-103B6	43.06	6.62	1.10	3.31	1.10	1.10	0.00	0.00	2.21
thalamus, adult, donor10252	10154-103A1	47.67	5.94	2.19	2.19	0.16	0.94	1.88	0.00	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	35.41	9.24	0.00	1.54	0.00	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.49	3.13	0.16	0.33	0.00	0.16	0.66	0.00	0.82
thalamus, newborn, donor10223	10366-105F6	20.14	4.03	1.15	1.73	0.00	0.00	0.58	0.00	0.58
throat, adult	10209-103G2	42.94	3.75	2.00	0.75	1.75	2.75	1.25	0.00	0.50
throat, fetal, donor1	10061-101H7	30.78	2.44	4.27	3.05	0.00	0.30	2.13	0.00	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	11.53	0.99	0.40	0.20	0.00	0.00	0.20	0.00	0.20
thymus, adult, pool1	10027-101D9	49.41	6.86	6.16	6.26	2.09	0.30	1.59	0.00	2.39
thymus, fetal, pool1	10043-101F7	79.38	11.74	9.56	4.36	2.60	0.31	1.66	0.00	1.66
thyroid carcinoma cell line:KHM-5M	10776-110G2	10.64	0.93	1.33	1.46	0.80	0.27	0.13	0.00	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	20.95	1.96	1.82	1.54	0.56	0.28	0.70	0.00	0.28
thyroid, adult, pool1	10028-101E1	37.70	5.04	2.89	1.12	0.56	1.40	1.68	0.00	0.65
thyroid, fetal, donor1	10060-101H6	43.77	2.64	1.85	1.32	0.26	1.58	0.79	0.00	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	6.16	6.16	9.24	3.08	3.08	0.00	0.00	3.08
tongue, adult	10203-103F5	24.19	2.79	1.86	1.16	2.09	3.02	0.70	0.00	0.23
tongue, fetal, donor1	10059-101H5	22.86	0.39	1.97	0.79	1.18	2.36	0.00	0.00	0.39
tonsil, adult, pool1	10047-101G2	45.58	3.21	4.61	1.70	1.00	0.90	0.90	0.00	0.90
trachea, adult, pool1	10029-101E2	28.38	2.37	2.70	2.04	0.65	0.98	0.57	0.00	0.65
trachea, fetal, donor1	10058-101H4	31.16	4.62	0.00	1.15	1.54	0.38	0.77	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	9.21	0.00	0.35	1.06	0.00	0.35	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	14.79	1.42	1.01	0.91	0.41	0.71	0.00	0.00	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	16.14	1.57	0.31	2.35	1.41	0.47	0.47	0.00	0.94
tridermal teratoma cell line:HGRT	10694-109G1	13.32	0.00	1.90	5.71	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	10.50	1.19	1.44	0.76	1.02	0.34	0.08	0.00	0.42
umbilical cord, fetal, donor1	10057-101H3	10.43	2.09	2.09	0.00	2.09	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	74.91	9.04	6.65	5.63	0.17	1.37	2.39	0.00	0.85
uterus, fetal, donor1	10055-101H1	26.11	7.17	2.56	2.05	1.54	0.51	0.00	0.00	1.02
vagina, adult	10204-103F6	45.88	12.28	1.29	3.88	0.00	1.29	2.58	0.00	2.58
vein, adult	10191-103E2	27.40	3.29	2.41	1.53	0.44	0.88	0.22	0.00	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.22	1.34	1.07	0.80	1.07	0.27	0.27	0.00	0.53